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Summary
Within this work, insights into the structure of the transcription initiation complex of
RNA polymerase (Pol) II as well as into the CTDK-I complex that promotes
transcription elongation were gained. During transcription initiation at promoters of
protein-coding genes, Pol II assembles with TBP, TFIIB, and TFIIF into a conserved
core initiation complex that recruits additional factors. The core complex stabilizes
open DNA and initiates RNA synthesis, and it is conserved in the Pol I and Pol III
transcription systems.
In the first part of this thesis, a protein-protein crosslinking approach was used
to identify side-specific distance restraints by using mass spectrometry (MS). With
this method, the domain architecture of the yeast core pol II initiation complex during
transcription initiation was derived. The yeast complex resembles the human initiation
complex and reveals that the TFIIF Tfg2 winged helix domain shows unexpected
movement and swings over promoter DNA. An ‘arm’ and a ‘charged helix’ in TFIIF
function in transcription start site selection and initial RNA synthesis, respectively,
and apparently extend into the active center cleft of Pol II. Our model provides the
basis for further structure-function analysis of the entire transcription initiation
complex.
The second part of this work focuses on CTDK-I, a yeast kinase complex, that
phosphorylates the C-terminal repeat domain (CTD) of RNA polymerase II (Pol II) to
promote transcription elongation. CTDK-I consists of the cyclin-dependent kinase
Ctk1 (homologous to human CDK12 and to a lower degree CDK9), the cyclin Ctk2
(homologous to human cyclin K), and the yeast-specific subunit Ctk3, which has
been shown to be required for CTDK-I stability and activity. Ctk3 consists of a non-
canonical CTD-interacting domain (CID) located at the N-terminal end and a
predicted three-helix bundle domain at the C-terminal. We determine the X-ray
crystal structure of the N-terminal domain of the Ctk3 homologue Lsg1 from the
fission yeast Schizosaccharomyces pombe at 2.0 Å resolution. The structure reveals
eight helices arranged into a right-handed superhelical fold that resembles the CID
domain present in the yeast transcription termination factors Pcf11, Nrd1, and Rtt103.
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Ctk3 however shows different surface properties and no binding to the CTD,
which was determined by fluorescence anisotropy binding assays. Together with the
known structure of Ctk1 and Ctk2 homologues, our results lead to a molecular
framework for future work to further analyze the structure and function of the CTDK-I
complex.
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1 Introduction
1.1 Gene	transcription	
The transcription of DNA to RNA molecules catalyzed by DNA dependent RNA
polymerases (Pol) represents a fundamental biological process found in all living
organisms. During gene transcription the generated RNA molecules often serve as
templates for protein synthesis1. Transcription in eukaryotes is carried out by three
different nuclear RNA polymerases: RNA polymerase (Pol) I, Pol II, and Pol III2. Pol I
synthesizes ribosomal RNAs (rRNAs), whereas Pol II produces all protein-coding
messenger RNA (mRNA), small nuclear RNAs (snRNAs) and small nucleolar RNAs
(snoRNAs). Finally, Pol III synthesizes transfer RNAs (tRNAs), 5S rRNA, and diverse
small RNAs3,4. In plants, a fourth (Pol IV) and fifth (Pol V) RNA polymerase
synthesize RNAs involved in gene silencing. For genome transcription in chloroplasts
and mitochondria, dedicated polymerases are present5,6. All RNA polymerases
exhibit homology within their largest subunits, ranging from bacterial over archaeal to
eukaryotes.
Pol I, II and III are multi-subunit complexes and share a conserved core of ten
subunits and additional subsets of up to seven subunits. Pol II is composed of 12
subunits Rpb1 to Rpb12, of which Rpb1 represents the largest subunit.
Rpb1 has a unique, highly repetitive C-terminal domain (CTD) which plays a
key role in the cycle of eukaryotic transcription (see Sections 1.4)7,8.
Introduction
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1.2 Transcription	cycle	and	the	chromatin	environment	
The Pol II transcription cycle has been divided into five defined phases: Transcription
pre-initiation, initiation, elongation, termination and re-initiation9,10. All transcription
cycle events are precisely coordinated and controlled. Specific subsets of accessory
proteins are needed to form complex networks which are required of regulation11.
In a higher level of complexity, the genome is organized as chromatin. Various
proteins are associated with chromatin, including the histones which are needed for
the compact packaging of the genome. Moreover, interactions of diverse factors,
such as histone modifying enzymes and chromatin remodelers may facilitate and
regulate gene expression (for a more detailed overview see Figure 1B)12.
Initiation1.2.1
Before initiation occurs, Pol II needs to bind the promoter DNA together with the
general transcription factors TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH to form a
pre-initiation complex13-15. In addition, the pre-initiation complex bind to large
coactivator complexes like Mediator or SAGA to facilitate transcription in different
gene classes16. Coactivators link signals from gene-specific activators which bind
upstream to the core promoter region (see Figure 1A)17. In the complete pre-initiation
complex, the double stranded DNA is melted (open complex) and the nascent RNA
molecules can be synthesized (initially transcribing complex)18,19. A detailed list of all
GTFs and the corresponding functions is depicted in Table 1.
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Figure 1 Promoter recognition and assembly of the pre-initiation complex.
(A) Binding of the activator to its enhancer sequence leads to the recruitment of the
GTFs which bind to the core promoter elements (CPEs): TATA box, upstream and
downstream B recognition element (BREu/d), Initiator sequence (Inr) and
downstream promoter element (DPE). The TATA box is occupied by the TBP
containing TFIID complex and TFIIB binds the BRE elements which play a role in the
recruitment of Pol II and TFIIF and further GTFs20. Histone modifying enzymes (e.g.
acetyltransferases, methyltransferases and nucleosome remodelers) alter the
chromatin environment which is required for transcription. (B) The assembled PIC
consists of the Pol II, GTFs and the mediator13. Nucleosomes which are close to the
promoter DNA comprise distinct histone modifications like methylation of H3K4 (at
the lysine 4 which of histone 3; yellow circles) and acetylation of H3K9/14 (green
triangles) for active gene transcription. The repetitive CTD tail of Pol II is hyper-
phosphorylated at position serine 5 (green circles). Adapted from12.
Introduction
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Table 1: Pol II, its corresponding General Transcription Factors and the coactivators.
Text in table was adapted from14
complex Subunits; Functions
Pol II 12; transcription of all mRNAs and a subset of noncoding RNAs including
snoRNAs and miRNAs
TFIIA 2–3; counteract negative cofactors; interact with activators and
components of the basal initiation machinery
TFIIB Single subunit; stabilizes TFIID-promoter binding; recruits TFIIF/Pol II to
the promoter; start site selection
TFIID 14; nucleates PIC assembly; coactivator activity through direct interaction
with gene specific activators
TFIIE 2; helps recruit TFIIH to promoters; stimulates helicase and kinase
activities of TFIIH; promoter melting
TFIIF 2–3; associated with Pol II; enhances affinity of Pol II for TBP-TFIIB-
promoter complex; recruitment of TFIIE/TFIIH to the PIC; start site
selection and promoter escape; enhances elongation efficiency
TFIIH 10; promoter opening and promoter clearance; transcription coupled
DNA repair; phosphorylation of Pol II CTD; transition from initiation to
elongation
Mediator At least 24; bridges interaction between activators and basal factors;
stimulates both activator dependent and basal transcription; required for
transcription from most Pol II dependent promoters
SAGA 20; interacts with activators, histone H3, and TBP; histone
acetyltransferase activity; deubiquitinating activity
Elongation1.2.2
To facilitate the transition from transcription initiation to the processive elongation
phase, a transcription elongation complex (TEC) needs to be formed, comprising its
own set of distinct proteins, the transcription elongation factors (EFs)21,22. The EFs
can influence the processivity and rate of Pol II as well as the chromatin environment
to guarantee and control the productive synthesis of nascent RNA molecules23-25.
TFIIS is a key player to stimulate the productive transcription state of Pol II, by
inhibition of promoter pausing, backtracking events and cleavage of the mRNA 25,26.
Introduction
16
Termination and re-initiation1.2.3
Transcription termination is coupled with the cleavage of the 3’-end of the
synthesized mRNA strand. Thereby, the polyadenylation (pA) site of the nascent
mRNA serves as a marker to initiate mRNA cleavage27. Downstream of the pA site
Pol II dissociates from the DNA template and transcription is terminated28,29.
To close the transcription cycle, Pol II and the GTFs can again re-initiate
another cycle of gene transcription. Some factors remain bound to the promoter DNA
such as: TFIID, TFIIE, TFIIF and the Mediator complex to facilitate a subsequent
round of transcription30.
Introduction
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1.3 Architecture	 of	 the	 core	 RNA	 polymerase	 II	 transcription	
initiation	complex	
The following introductory text in Section 1.3 was published.
Wolfgang Mühlbacher*, Sarah Sainsbury*, Matthias Hemann, Merle Hantsche, Franz
Herzog, and Patrick Cramer. Conserved architecture of the core RNA polymerase
IIinitiation complex. Nature comm. 2014;5:4310.
*These authors contributed equally.
From pre-initiation to the initially transcribing complex (ITC)1.3.1
During assembly of the transcription pre-initiation complex (PIC), the Pol II-TFIIF
complex binds to a TFIIB-TBP-DNA promoter assembly, resulting in a core initiation
complex31,32. The structure and function of the core initiation complex is conserved
from yeast to human, and also in the two other eukaryotic transcription systems33.
Pol I and Pol III both contain a TFIIF-like subcomplex, and they also use TBP and a
TFIIB-like factor for initiation. The conserved core initiation complex stabilizes open
promoter DNA and directs initial RNA synthesis, resulting in the initially transcribing
complex (ITC).
In the Pol II system, the core initiation complex additionally binds TFIIE and
TFIIH to form a complete pre-initiation complex (PIC). Architectural models of the
yeast Pol II PIC were obtained by site-specific protein cleavage mapping34-36. The
architecture of the human PIC was obtained by electron microscopy (EM)37, and
generally resembled that of the yeast PIC. Recently, an alternative model of the yeast
PIC was derived based on a combination of EM and protein crosslinking coupled to
mass spectrometry (XL-MS)38, raising the question whether the PIC architecture is
indeed conserved between eukaryotic species.
Introduction
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We have previously modelled the architecture of the core Pol II initiation
complex39 by structural superposition of our Pol II-TFIIB crystal structures40,41 with a
Pol II-TFIIF complex model obtained by XL-MS42. However, the model awaited
experimental confirmation because both TFIIF and TFIIB are modular factors with
flexible domains that may be repositioned upon complex assembly.
The N-terminal regions of TFIIF subunits Tfg1 and Tfg2 form a dimerization
module, whereas their flexibly linked C-terminal regions each include a winged helix
(WH) domain. TFIIB consists of a N-terminal zinc ribbon domain followed by the
reader and linker regions and two C-terminal cyclin domains.
Protein crosslinking of the ITC1.3.2
In the first part of the thesis we used protein-protein crosslinking and mass
spectrometric identification to derive a model of the core ITC from yeast. The yeast
complex resembles the previously published human counterpart37, indicating that the
core initiation complex is conserved between eukaryotic species. The results also
reveal a new element, the charged helix in the TFIIF subunit Tfg1, demonstrate that
the Tfg2 WH domain can swing over the DNA after it was loaded into the active
center cleft, and provide a basis for elucidating the architecture of the entire initiation
complex.
Introduction
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1.4 The	CTD	of	Pol	II	and	the	CTD	kinase	I	complex	(CTDK-I)	
Wolfgang Mühlbacher, Andreas Mayer, Mai Sun, Michael Remmert, Alan C.M.
Cheung, Jürgen Niesser, Johannes Soeding and Patrick Cramer. The RNA
polymerase II CTD kinase complex subunit Ctk3 contains a non-canonical CTD-
interacting domain. Proteins 2015; Accepted Article.
The Pol II C-terminal repeat domain (CTD)1.4.1
The CTD of Rpb1 in Pol II consists of 26 (yeast) and 52 (human) heptapeptide
repeats with the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser78,43. The
CTD serves as a binding platform for various factors during transcription, including
pre-mRNA processing factors. During the transcription cycle, the CTD changes its
phosphorylation pattern and this alters its binding affinity to factors7,21,44,45.
Phosphorylation at position Ser5 is associated with pre-mRNA capping in early
transcription elongation complexes46. Ser2 phosphorylation has been implicated in
both elongation and termination events. The CTD residues Tyr1, Thr4, and Ser7 can
also be phosphorylated47-50.
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Phosphorylation of the CTD1.4.2
CTD phosphorylation is accomplished by four different cyclin-dependent kinases
(CDKs) in yeast, namely Kin28, Srb10, Bur1, and Ctk17. The Kin28 kinase and its
human counterpart CDK7 are subunits of the initiation factor TFIIH and
phosphorylate the CTD at position Ser551-53. The Srb10 kinase associates with cyclin
Srb11 and resides within the Mediator coactivator complex. The Srb10-Srb11 pair
phosphorylates both Ser2 and Ser5 residues and is related to the mammalian pair
CDK8-cyclin C54,55. The CTD kinases Bur1 and Ctk1 are Ser2 kinases and both
share homology with mammalian CDK9, a subunit of positive transcription elongation
factor b (P-TEFb), which induces productive elongation56-58. Ctk1 is the main Ser2
kinase in yeast, whereas Bur1 phosphorylates both Ser2 and the elongation factor
Spt4/559,60,61. Bur1 also play a role in histone modification62. The transition from
transcription initiation to elongation requires, in addition to Ser2 phosphorylation,
dephosphorylation of Ser5 residues by Rtr1 and Ssu7263,64. Bur1 activity is controlled
by cyclin Bur258,65. Yeast Ctk1 and Bur1 kinases appear to be orthologues to
metazoan Cdk12 and Cdk9, respectively66.
The elongation promoting complex CTDK-I1.4.3
Ctk1 (also known as Lsk1 in S. pombe) associates with its cyclin partner Ctk2 (S.
pombe Lsc1) and a third subunit, Ctk3 (S. pombe Lsg1), to form the CTD kinase I
(CTDK-I) complex67-71. This trimeric structure is unique amongst CDK complexes68,72.
S. cerevisiae Ctk3 and S. pombe Lsg1 share 24% amino acid sequence identity, and
associate with Ctk1/Ctk2 and S. pombe Lsk1/Lsc1, respectively69-71,73,74. Throughout
this work, we refer to S. pombe Lsg1 as Ctk3. In S. cerevisiae, the activity of Ctk1
and Ctk2 are strongly dependent on the binding to Ctk367,75. The Ctk3 C-terminal
region is involved in the stabilization of the Ctk2-Ctk3 heterodimer and CTDK-I
function67. Recruitment of Ctk1 in vivo relies to some extent on the completion of the
pre-mRNA 5’-cap structure76, but there are additional, unknown mechanisms of
CTDK-I recruitment. Ctk3 may function in CTDK-I recruitment, although Ctk3 does
not have counterparts in metazoa68,72.
Materials and Methods
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2 Materials and Methods
2.1 Materials		
Bacterial and Yeast strains2.1.1
Table 2: Bacterial and Yeast strains.
Bacterial Strain Description Company
XL1- blue recA1 endA1 gyrA96 thi-1 hsdR17 supE4
relA1 lac(F’ proAB lacIqZDM15Tn10(Tetr))
Stratagene
BL21-(DE3)RIL B F- ompT hsdS(rB- mB-) dcm+ Tetr gal
l(DE3) endA The (argU ileY leuW Camr),
extra copies of argU ileY and leuW tRNA
genes on a COlE1-compatible plasmid with
chloramphenicol resistance marker,
protease deficiency, chromosomal T7-
polymerase gene
Stratagene
Rosetta B834
(DE3)
F- ompT hsdSB(rB- mB-) dcm+ metB,
methionine auxotroph
Novagen
Yeast Strain Description Company
BJ5464 His-Bio BJ5464 His-Bio tag introduced at 5’end of
Rpb3 gene, use of URA3 selection marker
(Kireeva et
al., 2000b)
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Plasmids and oligonucleotides2.1.2
Table 3: Plasmids used in this study.
Vector Species Insert Type Resistance. Source
WM01 Sc TBP (61-240), N-6xHis pET28b Amp MB
WM02 Sc TFIIB pOPINE Amp SS
WM03 Sc/Sm TFIIF pETduet  Amp KK
WM04 Sp Ctk3 full-length pET28b Amp This
work
WM05 Sp Ctk3 (1-140) pET28b Kan This
work
WM06 Ca Ctk3 (1-146) pET28b Kan This
work
WM07 Sc Ctk3 (1-149) pET28b Kan This
work
Sc, Saccharomyces cerevisiae; Sm, Saccharomyces mikatae; Sp, Schizozaccharomyces
pombe; Ca, Candida albicans; Kan, Kanamycin; Amp, Ampicillin; cloned by Kerstin Kinkelin,
KK; Michela Bertero, MB; Sarah Sainsbury, SS. A detailed list of DNA oligonucleotides used
for cloning can be obtained from the Cramer group.
Table 4: Oligonucleotides used for Protein crosslinking.
Type Sequence (5’ - 3’)
Template DNA  CGA GAA CAG TAG CAC GCT GTG TAT ATA ATA GTG
TGT TGT ACA TAG CGG AGG TCG GTG GGG CAC AAC
TGC GCT
Non-template
DNA
AGC GCA GTT GTG CTA TGA TAT TTT TAT GTA TGT ACA
ACA CAC TAT TAT ATA CAC AGC GTG CTA CTG TTC
TCG
RNA AUA UCA
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Growth media and additives2.1.3
Table 5: Growth media for E. coli and S. cerevisiae cultures.
Media Organism Description
LB E. coli 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract. 0.5
% (w/v) NaCl
SeMet E. coli 22 g/L SeMet base, 5g/L nutrient mix, 40 µg/mL
SeMet (Molecular Dimensions)
YPD S. cerevisiae 2 % (w/v) peptone, 2 % (w/v) glucose, 1 % (w/v)
yeast extract
Table 6: Additives for E. coli cultures.
Additive Application
Stock solution Applied
concentration
Ampicillin Antibiotic 100 mg/mL in H2O 0.1 mg/L
Chloramphenicol Antibiotic 30 mg/mL in
Ethanol
0.03 mg/L
Kanamycin Antibiotic 20 mg/mL in H2O 0.02 mg/L
IPTG Protein
expression
1 M in H2O 0.5 mM
IPTG = Isopropyl-β-D-1- thiogalactopyranoside.
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General buffers, markers and solutions2.1.4
Table 7: List of general buffers and solutions.
Name Description Application
Electrophoresis buffer 10x MOPS NuPAGE buffer (Life
Technologies)
SDS-PAGE
5x SDS sample buffer 250 mM Tris-HCl (pH 7.0 at 25°C); 50%
(v/v)
glycerol; 0.5% (w/v) bromophenol blue;
7.5%
(w/v) SDS; 500 mM DTT
SDS-PAGE
20 × MES SDS
running buffer
50 mM MES; 50 mM Tris Base; 0.1%
SDS;
1 mM EDTA; pH 7.3 at 25°C
SDS-PAGE
20 × MOPS SDS
running buffer
50 mM MOPS; 50 mM Tris Base; 0.1%
SDS;
1 mM EDTA; pH 7.7 at 25°C
SDS-PAGE
Broad range MW
marker
Bio-Rad SDS-PAGE
SDS-PAGE stain Instantblue (Expedion) SDS-PAGE
Coomassie gel
staining solution
50% (v/v) ethanol; 7% (v/v) acetic acid;
0.125%
(w/v) Coomassie Brilliant Blue R-250
SDS-PAGE
100x PI 0.028 mg/mL Leupeptin, 0.137 mg/mL
Pepstatin A, 0.017 mg/mL PMSF, 0.33
mg/mL Benzamidine in Ethanol
Protease
Inhibitor
10x TAE 50 mM EDTA pH 8, 2.5 M Tris-acetate Agarose gel
electrophoresis
SYBR Safe
(10,000 ×
in DMSO)
Invitrogen Agarose gel
electrophoresis
Gene Ruler 1 kb DNA
ladder (0.1 µg/µL)
Fermentas Agarose gel
electrophoresis
1 × TE 10 mM Tris-HCl (pH 8.0 at 25°C); 1 mM
EDTA
Oligonucleotides
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2.2 Common	Methods	
Molecular cloning2.2.1
Polymerase	Chain	Reaction	(PCR)	
Primers were designed by using an overhang of nucleotides at the 5’ end (5’ -
AGGAGGAGG- 3’), followed by a restriction side and 20 or more nucleotides
complementary to the gene sequence of interest. PCR reactions were carried out
with Phusion High-Fidelity DNA Polymerase (Finnzymes), in a 50 µL reaction
volume. 50 ng Synthesized oligonucleotide plasmids were used as template DNA.
0.5 pmol/µL PCR primers were used in each reaction. Reactions took place in
Biometra T3000 Thermocycler with 30 cycles. Primer annealing temperature and
synthesis time varied according to the length of DNA template and primer. PCR
products were visualized by using 1% agarose gel electrophoresis and Sybr-Safe
staining. Purification of the DNA was carried out with QIAquick gel extraction kit
(Quiagen).
Enzymatic	restriction	cleavage	
DNA was digested using restriction endonucleases from Fermentas and New
England Biolabs (NEB) as recommended in the producers guidelines. Cleaved PCR
products and plasmids were purified using the QIAquick-PCR purification and –gel
extraction kits (both Quiagen), respectively.
Ligation		
Digested DNA was ligated into linearized vectors at room temperature for 1 hour in a
volume of 20 µl using T4 DNA ligase and its corresponding buffer (Fermentas). A 5-
fold excess of insert, relative to the linearized vector was used.
Materials and Methods
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Transformation	and	sequencing	
Chemically competent E. coli XL-1 blue cells (Table 2) were mixed with 50 µL DNA
plasmids and transformed by heat shocking on 42 ⁰C for 45 sec. 700 µL LB Medium
was added and incubated at 37 ⁰C for 1 h. After sedimentation (30 sec, 14000 rpm),
the cells were re-suspended in 200 µL LB-Medium and transferred to LB-Agar plates,
containing the corresponding antibiotics for selection. The plates were incubatet at 37
⁰C over night. 5 mL LB media was inoculated by a single bacteria colony,
representing a single clone, and further incubated at 37 ⁰C over night and used for
the preparation of plasmid DNA using the QIAquick Miniprep Kit (Qiagen). Isolated
plasmids were verified by DNA sequencing (Company: GATC).
Protein expression in E. coli and complex formation2.2.2
Protein	expression	and	purification		
E. coli cultures were expressed and purified following the respective sections in 2.3
and 2.4. In general, cultures with volumes from 1-8 L LB were inoculated with 50 mL
pre-culture, which was incubated over-night. All cultures contained the antibiotics
corresponding to the resistance of the transformed vector. Cell were grown to a
target OD600 of 0.6-0.9 and induced by the addition of 0.5 mM IPTG to start protein
expression. Proteins were expressed at 18°C overnight. Recombinant proteins were
purified using affinity purification, ion exchange and subsequent size exclusion
chromatography.
Protein	concentrating,	and	storage	
Proteins were concentrated by AMICON Ultra spin concentrators (Millipore) with
defined molecular weight cutoffs, at least three-fold smaller than the target protein.
Protein concentration was determined by using the NanoDrop spectrophotometer
(absorption at 280 nm). Absorption coefficients were calculated by the ProtParam
tool (http://expasy.org/tools/protparam.html). Purified protein samples were frozen in
liquid nitrogen and stored at -80 °C.
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SDS-PAGE	analysis	and	protein	identification	
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used
to determine the stoichiometry and the approximate concentration of protein samples.
20 μL protein solution and 5 μl 5x sample buffer were mixed together and boiled at
95 °C for 3 min. 15 μL protein samples were loaded into the gel-pockets. Gel
electrophoresis took place at 100 mA for 30 min. Gel staining was accomplished
using InstantBlue (Expedeon) for 30 min. Protein samples were identified by mass-
spectrometry analysis from the protein core facility of the Adolf-Butenandt-Institute,
LMU.
DNA-RNA	Scaffold	preparation	
DNA and RNA oligonucleotides were separately dissolved in in 1x TE buffer at a
concentration of 400 µM. Dissolved oligonucleotides were mixed to reach an
equimolar concentration of 100 µM. Annealing took place in a T3000 Thermocycler
(Biometra) due to cooling from 95 °C to 10 °C in 1 °C steps occurring every 30
seconds. DNA-RNA scaffold was either directly used in complex formation or stored
at -20°C.
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Crystallization2.2.3
Initial	crystallization		
To determine initial crystallization conditions, protein samples were forwarded to the
MPI crystallization facility (Max Planck Institute of Biochemistry in Martinsried).
Protein samples were applied to diverse sparse matrix screens (96-well plates with
sitting drop vapor diffusion technique). All Screens were performed at both, 4 °C and
room temperature. Total size of the hanging drop was 200 nL (100 nL protein and
reservoir solution, respectively). Following screens from QIAGEN were used:
Classics; Classics Lite; AmSO4; Pegs; pH Clear 1, pH Clear 2. Further screens
originated from in house source: Crystal platform Magic 1; Crystal platform Magic 2
and from Hampton Research: Index screen.
Optimization	of	crystallization		
The optimization of initial crystallization was carried out manually in 15-well hanging
drop crystallization plates. In general, 1 μL pure protein was mixed with 1 μL
reservoir buffer and incubated over a 600 μL reservoir solution at either 20°C or 4°C.
The ratio of protein to reservoir solution was 1:1, 1:2, or 2:1.
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2.3 Specific	 methods	 for	 section	 3.1	 with	 focus	 on	 protein	
crosslinking	
The following text in Section 2.3 was published.
Wolfgang Mühlbacher*, Sarah Sainsbury*, Matthias Hemann, Merle Hantsche, Franz
Herzog, and Patrick Cramer. Conserved architecture of the core RNA polymerase
IIinitiation complex. Nature comm. 2014;5:4310.
*These authors contributed equally.
Preparation of the yeast core Pol II ITC2.3.1
Endogenous S. cerevisiae 12-subunit Pol II was prepared as described80. Full-length
TFIIB41, TFIIF (S. mikatae Tfg1, S. cerevisiae Tfg2)34 and TBP81 (residues 61-240)
were prepared as described. Pol II (0.77 mg, 3.5 mg ml-1) was incubated with a four-
fold molar excess of TFIIF, TFIIB, and TBP, and a two-fold molar excess of DNA-
RNA scaffold (Figure 2a) for 30 min at 298 K and for 5 min at 293K, 288K, and 283K.
Size-exclusion chromatography in 250 mM KCl, 20 mM HEPES pH 7.5, 5% glycerol,
and 2 mM DTT resulted in a stoichiometric ITC (Figure 2b).
Crosslinking and mass spectrometry2.3.2
0.9 mg purified ITC (1.2 mg ml-1) was incubated with an eight-fold molar excess of
DNA-RNA scaffold and crosslinked with 0.6 mM isotope-labeled disuccimidyl
suberate (DSS-d0/d12, Creative Molecules Inc.) as described82. Crosslinked protein
was digested, and the crosslinked peptides were enriched, analyzed by liquid
chromatography coupled to tandem mass spectrometer (Orbitrap EliteTM), and
spectra were searched by the xQuest software83,84. The resulting cross-link
identifications were manually validated and the local false discovery rates for each
individual cross-link were estimated as described. The term ‘crosslink’ describes a
peptide-peptide pair linked through two specific lysines. A single peptide-peptide
combination of peptides containing more than one lysine each can be identified by
distinct cross-links which represent a single unique distance restraint.
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Finally, we also detected 11 crosslinks, which linked to serine, threonine and
tyrosine with maximum Cα distances of 21.7 Å (Supplementary Table 3).
Nevertheless, these crosslinks presented no additional structural information.
Structural modeling2.3.3
All modeling was done manually. To generate the ITC model, we used PyMOL and
crosslinking restraints to place homology models of the yeast TFIIF dimerization
module and WH domains and the TFIIB C-terminal cyclin domain onto the Pol II-
TFIIB (PDB: 4BBR) open promoter complex model40. Models for the yeast TFIIF
dimerization module and WH domains and TFIIB C-terminal cyclin domain were
generated from known crystal structures (dimerization module, chains A and F in
PDB 1F3U; Tfg1 WH domain, PDB 1I27; Tfg2 WH domain, PDB 1BBY; TFIIB C-
terminal cyclin domain, chain A in PDB 1VOL) using MODELLER85. Residues 92-153
and 324-417 in S. cerevisiae Tfg1 correspond to residues 5-62 and 73-168 in human
Rap74. Residues 54-138 and 208-227 of S. cerevisiae Tfg2 align to residues 2-119
of human Rap30, respectively. Residues 678 – 736 of S. cerevisiae Tfg1 WH domain
align with residues 454 – 517 in human Rap74 and residues 292 – 350 in S.
cerevisiae Tfg2 WH domain align to residues 176 – 243 in human Rap30. Residues
125-345 of S. cerevisiae TFIIB C-terminal cyclin domain align to residues 113-316 in
the human counterpart. The Tfg1 sequence of S. mikatae was substituted with the
one of S. cerevisiae since they only differ in three amino acids in the dimerization
module model and in six in its winged helix model.
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2.4 Specific	methods	for	section	3.2	with	focus	on	crystallography	
Wolfgang Mühlbacher, Andreas Mayer, Mai Sun, Michael Remmert, Alan C.M.
Cheung, Jürgen Niesser, Johannes Soeding and Patrick Cramer. The RNA
polymerase II CTD kinase complex subunit Ctk3 contains a non-canonical CTD-
interacting domain. Proteins 2015; Accepted Article.
Sample preparation2.4.1
DNA constructs of S. pombe full-length Ctk3 (residues 1-218) and the Ctk3 N-
terminal domain (residues 1-140) were synthesized (Mr. Gene GmbH) and cloned
into pET28b+ expression vector (Novagen) resulting in C-terminal hexahistidine tags.
Both, Ctk3 (1-218) and Ctk3 (1-140) protein variants were expressed overnight at
18ºC in Escherichia coli (E. coli) BL21 (DE3) RIL cells (Stratagene). E. coli strain
B834 (DE3) pLsyS (Novagen) was used for selenomethionine (SeMet) labeling. Cells
were harvested and resuspended in 50 mM Tris-HCl pH 8.0, 300 mM NaCl and 2 mM
DTT, followed by sonication. The resulting slurry was cleared by centrifugation. The
cleared lysate was subjected to affinity chromatography on a Ni-NTA column
(Qiagen) before dialyzing against 50 mM Tris-HCl pH 8.0, 50 mM NaCl and 1 mM
DTT to reduce the high imidazole concentration. The hexahistidine tag was removed
by thrombin cleavage at 4ºC overnight. The protein variants were further purified by
anion exchange chromatography (MonoQ column, GE healthcare life science). After
size exclusion chromatography (Superpose-12 column, GE healthcare life science) in
gelfiltration buffer (50 mM HEPES pH 8.0, 50 mM NaCl, 1 mM DTT), the pure protein
was concentrated to 14.5 mg ml-1.
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Crystal structure determination2.4.2
Crystals for the Ctk3 N-terminal domain variant (residues 1-140) were grown at 4ºC
using hanging-drop vapour diffusion. The reservoir solution contained 26% PEG
6000, 100 mM citric acid pH 4.0, 0.8 M lithium chloride and 5 mM Tris(2-
carboxyethyl)phosphin (TCEP). Grown crystals were transferred to reservoir buffer
containing 10% PEG400. Diffraction data were collected at the Swiss Light Source
(SLS) in Villigen, Switzerland. Data were processed by XDS and scaled using
XSCALE86. The crystal structure was solved by multiwavelength anomalous
diffraction (MAD) from SeMet-labeled crystals using SOLVE87. Density modification
was carried out with RESOLVE87. An initial model was automatically built with
ARP/wARP88. Manual model building was carried out in Coot89. The model was
refined by PHENIX90 using individual isotropic B-factors and bulk solvent correction
to a free R-factor of 25.4% at 2.0 Å resolution.
Peptide interaction analysis2.4.3
We measured the protein-peptide interactions by fluorescence anisotropy. The
synthetic CTD peptides were labelled by N-terminal aminocaproic-linked fluorescein.
Changes in fluorescence anisotropy of the peptide solution were measured by
titration of Ctk3 N-terminal domain or full-length Ctk3 (FluoroMaxP, HORIBA). All
peptides were dissolved in 20 mM HEPES pH 8.0, 10 mM NaCl and 5 mM DDT, and
adjusted to a concentration of 0.4 mM. Ctk3 N-terminal domain and full-length Ctk3
proteins were dissolved in gelfiltration buffer. The FluoroMaxP analyzer was
calibrated at 20ºC with gelfiltration buffer and 1 µL peptide in a quartz cuvette (0.4
mM). Before analysis, solutions were mixed by magnetic stirring for 1 min and
incubated for an additional minute. The protein solution was titrated to the peptide
solution in steps of 20 µL, and three measurements were recorded to enable
calculation of an arithmetic average. The excitation wavelength was set to 495 nm
(slit width = 2) and the emission wavelength to 520 nm (slit width = 1).
Results and Discussion
33
3 Results and Discussion
3.1 Conserved	 architecture	 of	 the	 core	 RNA	 polymerase	 II	
initiation	complex	
The following text in Section 3.1 was published.
Wolfgang Mühlbacher*, Sarah Sainsbury*, Matthias Hemann, Merle Hantsche, Franz
Herzog, and Patrick Cramer. Conserved architecture of the core RNA polymerase
IIinitiation complex. Nature comm. 2014;5:4310.
*These authors contributed equally.
Preparation and crosslinking analysis of the core ITC3.1.1
To experimentally define the domain architecture of the core initiation complex, we
reconstituted a defined yeast core ITC. We previously noted that a stable, defined
ITC can be formed by including a 6 nt RNA product41. We therefore incubated
purified Pol II, TFIIF, TFIIB, and TBP with a DNA-RNA scaffold (Figure 2a) and
obtained a stable core ITC after size exclusion chromatography (Figure 2b) (see
Online Methods). We then analysed this complex by XL-MS. The power and reliability
of XL-MS was recently exemplified by a high agreement between Pol I models
derived from XL-MS82 and subsequently from X-ray analysis91.
We obtained a total of 472 high-confidence lysine-lysine protein crosslinks
(332 distance restraints) within the core ITC (Supplementary Table 1 and 2), of which
241 were inter-subunit and 231 were intra-subunit crosslinks (Table 8). A total of 194
crosslinks within Pol II were readily explained with the Pol II crystal structure92.
Another 33 crosslinks were observed between TFIIF subunits Tfg1 and Tfg2, and
could be explained with the TFIIF dimerization module structure93. Only 18 crosslinks
showed Cα distances above the maximum expected distance of 27±3 Å42 (Figure
2c).
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Most of these could be explained by the known structural flexibility and higher
crystallographic B-factors of the involved lysine residues, leaving only three
crosslinks unexplained. Within TFIIB and TBP, 23 and six intramolecular crosslinks
were observed, respectively, and could be explained with crystal structures40,41,94,95.
These multiple internal controls demonstrate the high reliability of the observed
crosslinking data.
Positions of TFIIB and TFIIF3.1.2
We also observed 111 intermolecular crosslinks between transcription factors and
Pol II (Table 8) that allowed us to model the core yeast ITC (Figure 3a). Of these
crosslinks, 21 were observed between the TFIIF dimerization module and the Pol II
lobe and protrusion domains, showing that the module remains at its location
observed in the binary Pol II-TFIIF complex35,42. Further, 16 crosslinks were obtained
between the TFIIB linker and the Pol II domains clamp core, protrusion, and wall.
Another six crosslinks were detected between the N-terminal TFIIB cyclin domain
and the clamp core, protrusion and wall. The C-terminal cyclin domain did not
crosslink to Pol II, consistent with its mobility40.  All  TFIIB-Pol  II  crosslinks  were
explained with our crystal structures of the Pol II-TFIIB complex40,41, demonstrating
that TFIIB binds Pol II as observed in the binary structure. These results were
corroborated by crosslinks between the TFIIF subunit Tfg2 to TBP (one crosslink)
and to the N-terminal cyclin domain of TFIIB (six crosslinks).
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The Tfg2 WH domain swings over DNA in the cleft3.1.3
The crosslinking data also revealed that in the reconstituted core ITC the WH domain
in Tfg2 can reside at a position near upstream DNA on the outside of Pol II42, but also
at a position above the DNA in the active center cleft (Figure 3a, d). Thus, in the core
ITC, the WH domain remains flexible and adopts both alternative positions. The
original WH position near upstream DNA42 gives  rise  to  13  crosslinks  to  the  Pol  II
subunits Rpb2, Rpb3, and Rpb10. The new position above the Pol II cleft was
defined by four crosslinks of the WH domain to the clamp, TBP, and the TFIIB N-
terminal cyclin domain. These restrains can be satisfied when one assumes a
position of the WH domain with respect to promoter DNA that resembles that in a
known X-ray structure of a WH domain bound to DNA96. This position is also
consistent with a recent mapping of the DNA-binding face of the Tfg2 WH domain97.
These results indicate that the Tfg2 WH domain can swing over promoter DNA
after its loading into the Pol II cleft, and indicate a role of this domain in DNA melting
and/or stabilization of the open complex and the ITC. Indeed, this domain binds DNA
and is required for initiation98, and TFIIF suppresses abortive initial transcription99.
The proximity of the Tfg2 WH domain to TFIIB indicates how TFIIF could stabilize
TFIIB on Pol II during initial transcription100. The position of the Tfg2 WH domain
above the cleft apparently represents its position in a complete ITC. This position is
near TFIIE and TFIIA in the PIC37,38, and is likely stabilized upon TFIIE and/or TFIIA
binding. The other WH domain in TFIIF subunit Tfg1 only gave rise to a single
crosslink at the Pol II jaw, and does not adopt a defined location42.
Results and Discussion
36
Model of the yeast core ITC3.1.4
Based on the large number of protein crosslinks we built a reliable three-dimensional
model of the yeast Pol II core ITC. First, we derived a homology model of the yeast
TFIIF dimerization module based on the human crystal structure93. Second, we
positioned the resulting yeast TFIIF dimerization module model onto the Pol II-TFIIB-
DNA-RNA crystal structure41 assuming the location of the human module detected by
EM37. Third, we extended DNA both upstream and downstream using standard B-
form duplexes.
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Figure 2: Preparation and XL-MS analysis of the yeast core ITC.
(A) DNA-RNA scaffold based on a HIS4 DNA promoter with a mismatched bubble
region containing a 6 nt RNA transcript formi ng a hybrid duplex with the DNA
template strand41. (B) SDS-PAGE analysis of the purified Pol II ITC revealing its 16
polypeptide subunits. (C) Cα distance distribution for observed lysine-lysine crosslink
pairs (unique distance restraints). Crosslinks with distances of 30-39 Å are
explainable due to protein mobility (four crosslinks) or because of lysine location in
mobile protein loops with high crystallographic B-factors (14 crosslinks). Only three
crosslinks cannot be explained and are classified as outliers. (D) Crosslink map of
the ITC. Crosslinks within Pol II were excluded for clarity. TFIIB and Pol II subunits
are colour-coded as before41 and TBP and TFIIF were coloured as in Figure 3. The
map was generated with a MATLAB® script by coauthor Simon Neyer (see
Supplementary Material 1).
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TFIIF arm and charged helix3.1.5
In the resulting model, the Tfg1 ‘arm’ (a b-hairpin comprising yeast residues 146-153
and 319-338) extends from the TFIIF dimerization module, traversing between the
Pol II protrusion and lobe domains into the active center cleft (Figure 3c). The arm
forms 19 crosslinks in the cleft, consistent with detection of the arm in the human PIC
by EM37. A mutation at the point where the arm extends from the dimerization module
leads to shifts in the transcription start site101.
A second extension from the TFIIF dimerization module, a negatively charged,
flexible93 α-helix at the beginning of the ‘charged region’ in Tfg1 (named here the
‘charged helix’, yeast residues 406-417) clashed with the Pol II lobe. A reorientation
of the charged helix towards the jaws released this clash and explained 6 crosslinks
of the charged helix to the Pol II cleft. The location of the charged helix explained a
distinct EM difference density that was hypothesized to stem from the corresponding
human TFIIF region37.
Published mutational and kinetic data revealed important roles of the charged
helix in transcription initiation and elongation102,103. These roles can now be
rationalized due to the location near downstream DNA (Figure 3c). The charged helix
apparently repels the downstream DNA from the lobe, positioning it along the clamp
head on the opposite side of the cleft. This may help to stabilize melted DNA and to
align the DNA template in the active site and account for the known role of the
charged helix in stimulating initial RNA synthesis104.
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Conclusion3.1.6
Our crosslinking data and detailed architectural model of the core yeast ITC agree
with previous site-specific protein cleavage mapping of the yeast PIC34,35,105. Our
model further agrees with structural analysis of human Pol II PIC intermediates by
EM37. Thus the architecture of the core ITC is highly conserved between yeast and
human. Domains in TFIIF and TFIIB adopt very similar locations on the Pol II surface
in both species, although the position of the Tfg2 WH domain above the cleft may
change slightly upon binding TFIIA and/or TFIIE or different DNA template
sequences. Furthermore, two TFIIF motifs extending from the dimerization module,
the arm and charged helix, adopt the same locations in the downstream cleft. Our
results also indicate that the overall domain architecture of the initiation complex is
generally maintained during the transition from a PIC to an ITC.
Finally, our core ITC model can explain the XL-MS data obtained recently with
a complete yeast PIC38. In the latter study, 117 distance restraints were obtained for
Pol II, TFIIB, TFIIF and TBP. Of these, only one crosslink disagrees with our model,
which was derived from 472 crosslinks with 332 distance restraints. Apparently the
published study38 contains correct crosslink information, but conflicting electron
microscopic results, which have apparently led to an alternative initiation complex
model. With respect to the core ITC, the discrepancies are now resolved. Our results
lead to a unified, highly conserved architecture of the core transcription initiation
complex. The location of the remaining general transcription factors TFIIE and TFIIH
differs to some extent in three published studies36-38 and may be analyzed in the
future.
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Table 8: Observed lysine-lysine crosslinks in the yeast core Pol II ITC.
Provided is the number of crosslinks between certain parts of the ITC, referring to unique
distance restraints.
ITC parts Crosslinks
(all)
Crosslinks
(mapable)
All (inter and intra crosslinks) 472 328
inter crosslinks
All 241 164
Pol II-Pol II 90 90
Pol II-TFIIF 84 40 (48)1
Pol II-Tfg1/2 dimerization module2 25 (29) 25 (29)
Pol II-Tfg1 WH 1 1
Pol II-Tfg2 WH 14 (17) 14 (17)
Pol II-TFIIB 27 23
Tfg1-Tfg2 33 11
TFIIB-Tfg2 6 0 (1)
TBP-Tfg2 1 0 (1)
intra crosslinks
All 231 164
Pol II 104 104
TFIIF 98 32
Tfg1/2 dim.-module2 4 4
Tfg1 WH-model 18 18
Tfg2 WH-model 11 11
TFIIB 23 22
TBP 6 6
1Numbers in brackets include crosslinks that involve amino acids located no more
than three residues away from residues within known structures.
2Residues from the charged region of Tfg142 (400-417) and N-terminal region (92-98)
are also part of the dimerization model based on the human X-ray structure.93
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Figure 3: Crosslinking-derived model of the yeast core ITC.
(A) Top view of the ITC, highlighting the locations of TBP (red), TFIIB (green), and
TFIIF subunits Tfg1 (light blue) and Tfg2 (pink) on the Pol II surface. The TFIIF arm
and charged helix elements are indicated as an antiparallel β-hairpin and α-helix,
respectively. Alternative positions of the Tfg2 WH domain are indicated with black
circled numbers (1, outside the cleft near upstream DNA as in the Pol II-TFIIF binary
complex; 2, at the DNA bubble above the cleft). Mobile linkers are shown as dashed
lines. (B) Pol II-TFIIB crosslinks (blue lines) viewed from the top as in (a) can be
explained with the previously derived crystallographic TFIIB (B) core and ribbon
domain locations40,41. (C) Location of the Pol II-TFIIF dimerization module (pink and
yellow lines depict inter- and intra crosslinks, respectively). (D) The Tfg2 WH domain
adopts two distinct locations. At position 1, the Tfg2 WH domain crosslinks to Pol II
(pink lines), and at position 2, it crosslinks additionally to TFIIB and TBP (orange and
red lines, respectively). (E) Domain organization of TFIIF subunit Tfg1 and location
and conservation of the arm and charged helix elements. The charged helix was
partially resolved in the X-ray structure93 and is predicted to be longer106. Residues
required for normal transcription initiation and elongation102 are indicated as grey
asterisks.
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3.2 The	 RNA	 polymerase	 II	 CTD	 kinase	 complex	 subunit	 Ctk3	
contains	a	non-canonical	CTD-interacting	domain	
Wolfgang Mühlbacher, Andreas Mayer, Mai Sun, Michael Remmert, Alan C.M.
Cheung, Jürgen Niesser, Johannes Soeding and Patrick Cramer. The RNA
polymerase II CTD kinase complex subunit Ctk3 contains a non-canonical CTD-
interacting domain. Proteins 2015; Accepted Article.
Architecture of Ctk33.2.1
In the final part of the thesis we investigate the structure of Ctk3. We predict a
possible CTD-binding domain (CID) in the N-terminal region of Ctk3. The CID fold
consists of eight α-helices in a right-handed superhelical arrangement and was thus
far discovered in the three yeast proteins Pcf11, Nrd1, and Rtt10377-79. We use X-ray
crystallography to show that Ctk3 indeed contains a CID fold. However, unlike other
CID domains, this domain does not bind the Pol II CTD. We therefore refer to this
domain as ‘CID-like domain’. In addition, we predict a three-helix bundle in the C-
terminal region of Ctk3.
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Prediction of a CID domain in Ctk33.2.2
We tried to predict a possible structure and function of Ctk3 by using HHblits107, an
iterative sequence search tool that represents both query and database sequences
by profile hidden Markov models (HMMs). Such alignment methods are the most
sensitive class of sequence search methods and the best choice for structure
prediction and 3D homology modelling. We started with the protein sequence of Ctk3
and generated a profile HMM by performing two iterations of HHblits against the
UniProt20 database, a clustered profile HMM database with 20% maximum pairwise
sequence identity based on the UniProt sequence database (www.uniprot.org). The
resulting profile HMM was then used for a final search against the PDB70 database,
a clustered version of the protein data bank (PDB) filtered to 70% maximum pairwise
sequence identity.
In this search, the best matches to Ctk3 were the three known CIDs present in
the yeast genome. These reside in the transcription termination factors Rtt103,
Pcf11, and Nrd1, and gave rise to predicted probabilities of 98%, 94%, and 93%,
respectively. The matched alignment covered the entire CID, except for a weakly
conserved C-terminal helix where the confidence values were lower. Based on these
three alignments we generated a structural model of Ctk3 with the use of the
MODELLER software85. The Ctk3 model showed a high conservation in the N-
terminal five helices of the CID with an insertion between the first and second helix of
approximately 20 amino acid residues in length.
The detected similarities strongly suggested that Ctk3 contains a CID, thus
apparently representing a forth CID-containing protein in the yeast genome.
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Crystal structure analysis of Ctk3 N-terminal domain3.2.3
To clarify whether Ctk3 indeed contains the predicted CID fold, we prepared the
putative CID-containing region of Ctk3 from S. pombe (Ctk3 (1-140), Figure 4) in
recombinant form after overexpression in E. coli (Materials and Methods). The Ctk3
N-terminal domain was purified and crystallized by vapour diffusion (Materials and
Methods). X-ray diffraction data were collected at the Swiss Light Source to a
resolution of 2.0 Å (Table 9). The structure was determined by selenomethionine
(SeMet) incorporation and multiwavelength anomalous diffraction (MAD) phasing,
and the resulting model was refined to a free R-factor of 25.4% and showed very
good stereochemistry (Materials and Methods). The overall fold of the Ctk3 N-
terminal domain consists of eight α-helices in a right-handed superhelical
arrangement (Figure 5A). As predicted, the fold closely resembles the known CID
domains in the S. cerevisiae proteins Rtt103, Pcf11, and Nrd1, and in the human
protein SCAF8 (Figure 5B). Superposition of the known CID structures revealed a
difference in helix α2 of Ctk3 (residue 19-21), which is bent at its residue Pro27
towards helix α4 that flanks the proposed CTD-binding region of Ctk3 (Figure 5B).
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Table 9: Crystallographic diffraction data and refinement statistics.
Data processing
Space group P43212
Unit cell dimensions (Å) a=b= 51.3, c= 119.1
Peak Inflection Remote
Wavelength (Å) 0.97964 0.98012 0.97197
Resolution (Å) 47.1–2.00
(2.05–
2.00)a
47.2–2.50
(2.57–2.50)
47.2–2.15
(2.21–2.15)
No. of observed reflections 157,934 80,837 126,934
No. of unique reflections 20,524 10,523 16,590
Completeness (%) 100 (99.9) 100 (100) 100 (100)
I/σ(I) 20.9 (4.9) 17.1 (5.1) 22.1 (5.0)
Rmerge (%) 8.2 (32.8) 10.4 (32.9) 7.8 (32.4)
Rmeas (%) 8.3 (48.8) 11.0 (46.7) 7.8 (47.4)
Wilson B value (Å2) 27.8 33.3 31.4
Refinement
Resolution range (Å) 47.12–2.0 (2.05–2.0)a
No. of protein atoms 1194
Amino acid residues 140
Water molecules / ionic molecules (EPE
ligands)b
67 / 2
R-factor / free R-factor (%) 20.04 / 25.28
B-factor average / macromolecules /
ligands / solvent (Å2)
33.20 / 31.50 / 74.00 / 42.70
Ramachandran plot:
Favoured / allowed / disallowedc (%)
99.3 / 100.0 / 0.0
RMSD bond lengths / bond angles 0.008 Å / 1.047º
aValues in parentheses refer to the highest resolution shell.
b4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.
cAs calculated using MolProbity 108.
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Figure 4: CTDK-I domains and conservation of Ctk3 N-terminal domain.
(A) Domain architecture of the three S. pombe CTDK-I subunits Ctk1 (Lsk1), Ctk2
(Lsc1), Ctk3 (Lsg1). (B) Structural alignment of S. pombe Ctk3 (Lsg1) N-terminal
domain (1-140) to known CID domains. Conserved residues are colored yellow,
invariant residues green. Sequences were ordered from highest (top) to lowest
conservation, relative to S. pombe (Sp, Schizosaccharomyces pombe; Sc,
Saccharomyces. cerevisiae; Hs, Homo sapiens). α-Helices are indicated above the
alignment. Residues forming the hydrophobic core are depicted with black triangles.
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(C) Alignment of Ctk3 N-terminal domains in different yeast species (Pb,
Paracoccidioides brasiliensis; Kp, Komagataella pastoris; Ca, Candida albicans).
Alignments were performed by ClustalW2 and the results were visualized by ESPript
3.0, using default values and “%Equivalent” as similarities depiction parameters
109,110.
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Figure 5: Crystal structure of the Ctk3 N-terminal domain at 2.0 Å resolution.
(A) Two views of a ribbon representation of the Ctk3 N-terminal domain, related by a
90 degree rotation around a horizontal axis. Residues that partially occupy the space
of the surface region corresponding to the CTD-binding groove in canonical CID
domains are depicted in red. The CTD-binding groove is indicated with black dashed
lines and is corresponding to the CID in Sc Pcf11 77. (B) Superposition of known CID
structures onto the Ctk3 N-terminal domain reveals its similarity to the CID fold. The
key structural difference between the Ctk3 CID-like domain and the canonical CIDs is
shown in red (part of helix α2 in Ctk3). The N- and C-termini of the protein domains
are indicated.
Results and Discussion
51
The Ctk3 N-terminal domain has a non-canonical surface3.2.4
To analyze whether the CID fold in Ctk3 also shares surface properties with
canonical CID domains, we analyzed the conservation and electrostatic properties of
the domain surface. We first colored the molecular surface of our structure according
to conservation of amino acid residues over species (Figure 6A, alignment Figure
4C). Comparison with the surface of CID domains in Rtt103, Pcf11, and Nrd1
revealed that the Ctk3 N-terminal domain has a distinct surface conservation.
Whereas canonical CID domains show a very high conservation of the CTD-binding
groove between helices α2, α4 and α7, Ctk3 only shows weak and partial
conservation in this region (Figure 6A). Moreover, Ctk3 residues Q21 and K111
partially obstruct the region corresponding to the CTD-binding groove in CID domains
(Fig 2A).
The Ctk3 N-terminal domain also differs from canonical CID domains with
respect to its surface charge distribution. To determine the charge distribution on the
surface of the structure we used the APBS Tool via PyMOL (Figure 6B)111. For the
canonical CID structures in Rtt103, Pcf11 and Nrd1, the conserved CTD-binding
groove is positively charged, as required for binding to the negatively charged,
phopshorylated CTD. In contrast, the corresponding region of the Ctk3 N-terminal
domain is mainly positively charged. Taken together, analysis of the surface
properties of the Ctk3 domain revealed that the putative CTD-binding groove was not
conserved and differently charged, arguing against a CTD-binding function.
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Figure 6: Surface properties of the Ctk3 N-terminal domain structure.
(A) Lack of a conserved CTD-binding groove in the Ctk3 N-terminal domain. The area
corresponding to the CTD-binding groove in the CID domain of Pcf11 is indicated by a black
dashed line 77. Surface model generated by ESPript 3.0 110 and colored according to
conservation as in Figure 4C. The alignment in Figure 1C was used as an input for ESPript.
Residues that partially occupy the space of the surface region corresponding to the CTD-
binding groove in CID domains are labeled in red. (B) Electrostatic surface potentials of Ctk3
N-terminal domain. Positive and negative charges are in blue and red, respectively. Surface
potentials were calculated with APBS 111.
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The Ctk3 N-terminal domain does not bind CTD-derived petides3.2.5
Structural analysis of Ctk3 revealed the fold of a CID domain, but also surface
features that clearly differ from canonical CID domains and therefore question
whether Ctk3 binds directly the CTD. To test CTD binding, we used a fluorescence-
based phosphopeptide interaction assay in solution. We monitored changes in
fluorescence anisotropy of fluorescently labeled CTD peptides upon addition of
increasing amounts of purified Ctk3 N-terminal domain. The peptides were based on
a di-heptad sequence (Figure 7A), which represents the functional unit of the Pol II
CTD112 and comprise different phosphorylation sites, mimicking various
phosphorylation states of the CTD that are adopted during the transcription cycle.
We tested binding of CTD peptides phosphorylated at positions Tyr1, Ser2,
Ser5, or Ser7, or phosphorylated at both Ser2 and Ser5, and also used a non-
phosphorylated di-heptad peptide as a control (Figure 7A). We did not observe any
binding of the Ctk3 N-terminal domain to any of the CTD-based peptides under the
conditions tested (Figure 7B). As a positive control we reproduced binding of purified
S. pombe Pcf11-CID to one of the Ser2-phosphorylated peptide, which demonstrated
that the assay was working very well under our conditions. The data obtained from
the positive control titration could be fit to the Hill equation as expected (Figure 7B).
Taken together, we were unable to detect any binding of the Ctk3 N-terminal domain
to any of the CTD-based peptides, strongly indicating that the domain does not
directly bind the CTD in vitro.
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Figure 7: Ctk3 N-terminal domain does not bind CTD phosphopeptides.
(A) CTD-derived diheptad repeat peptides with phosphorylation positions indicated. From top
to bottom, sequences of Tyr1-, Ser2-, Ser5-, Ser2,5- and Ser7-phosphorylated peptides are
given. (B) Fluorescence anisotropy titration curves, using purified Ctk3 N-terminal domain
(residues 1-140) and fluorescently labeled peptides shown in panel A. All measurements
based on technical triplicate data. Plotted are the mean and standard deviation. As a positive
control, we monitored binding of purified Pcf11-CID to Ser2-phosphorylated CTD peptide
(green113). Ser2-phosphorylated binding was additionally measured with full-length Ctk3
(residues 1-218).
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Ctk3 contains a highly conserved C-terminal bundle domain3.2.6
In order to gain structural insights also into the C-terminal region of Ctk3, we returned
to bioinformatic analysis. S. pombe Ctk3 residues 153-215 were annotated as a
possible conserved domain in the PFAM database (http://pfam.xfam.org/). This
region shows even higher sequence conservation than the N-terminal domain of Ctk3
(Figure 8A). We used the prediction algorithm PSIPRED114 to assign potential
secondary structure to this region. This revealed three helical stretches in this region
that we named putative helices α1, α2, and α3 (Figure 8A). Throughout different
yeast species, helices α2 and α3 were only weakly conserved, whereas helix α1 was
highly conserved, showing 163 yeast species comprising helix α1 (Ctk3 residues
153-183) in a BLAST search (conservative expect threshold of 1e-6)115. We
generated a three-dimensional model for the Ctk3 C-terminal region with the I-
TASSER software116, which uses structural templates from the Protein Data Bank.
The model with the highest score was a three-helix bundle (Figure 8B). Analysis of
the model revealed a conserved putative hydrophobic core, supporting the accuracy
of the prediction, and a conserved surface patch on helix α1 that may be involved in
interactions with other regions of CTDK-I.
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Figure 8: The Ctk3 C-terminal region contains a predicted helical bundle domain.
(A) Sequence alignment and secondary structure prediction of Ctk3 C-terminal region
comparing different yeast species. Conserved and invariant residues colored yellow and red,
respectively. Sequences ordered from highest conservation (on top) to lowest, relative to S.
pombe Ctk3 C-terminal domain (153-215). (Sp, Schizosaccharomyces pombe; Pb,
Paracoccidioides brasiliensis; Sc, Saccharomyces cerevisiae; Ca, Candida albicans; Kp,
Komagataella pastoris). α-Helices are indicated above the alignment. Residues forming the
hydrophobic core are depicted with black triangles. (B) Two views of the predicted Ctk3 C-
terminal domain model obtained with I-TASSER 116. The N- and C-termini of the protein
domain are indicated.
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Conclusion3.2.7
Here we predicted that Ctk3 consists of an N-terminal CTD-interacting domain (CID)
and a C-terminal helical bundle domain. X-ray crystallography confirmed the N-
terminal CID fold despite the low sequence conservation, consistent with the general
observation that the three-dimensional structure of proteins is more conserved than
their sequence. The Ctk3 N-terminal domain however differs from canonical CID
domains in its surface conservation and charge distribution. In particular, the putative
CTD-binding groove between helices α2, α4, and α7 is not conserved and lacks
positively charged residues. Consistent with this, the N-terminal domain of Ctk3 failed
to bind CTD phosphopeptides in solution. The CID fold resembles the fold of VHS
(Vsp27p/Hrs/STAM) domains117, as detected by DALI118. Thus the N-terminal domain
in Ctk3 could have arisen from a CID domain that lost its CTD-binding surface
groove, or from a VHS domain of unknown function.
The C-terminal domain of Ctk3 is more conserved than its N-terminal domain,
especially at its putative α1 helix. It remains unclear whether the C-terminal domain
of Ctk3 associates stably with the N-terminal domain or whether it forms a distinct
domain connected with a short linker. Consistent with a two-domain, flexible
structure, our attempts to crystallize full-length Ctk3 failed. The predicted C-terminal
domain is essential for cell growth in S. cerevisiae, and a truncation that removes
most of the C-terminal domain destabilizes the interaction of Ctk3 with Ctk2 in vitro,
whereas interaction with Ctk1 was maintained67. From these results and
considerations, a topological model of CTDK-I emerges with Ctk1 and Ctk2 forming a
canonical kinase-cyclin pair, as observed for pTEF-b119 and Ctk3 being anchored to
Ctk2 via its C-terminal helical bundle domain (Figure 9). In this model, the newly
found N-terminal domain in Ctk3 remains available for other, currently unknown
functions.
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Figure 9: Overview of CTDK-I architecture.
Relative size of the structure of mammalian Ctk1-Ctk2 counterpart CDK12–Cyclin K (PDB-
code 4UN0) and S. pombe Ctk3 N-terminal domain structure (this work) and predicted C-
terminal domain (this work). Arrow indicate putative interaction of the C-terminal domains
with Ctk2 (compare text). The active center of the CDK12 kinase structure is indicated with a
black dashed circle. The N- and C-termini of the proteins are labeled.
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4 Outlook
4.1 The	architecture	of	Pol	II	initiation	complexes	
Most of the fundamental mechanisms of transcriptional regulation are conserved from
yeast to human, assigning the S. cerevisiae model system a central role in
understanding how gene expression is controlled in all eukaryotes13. Protein
crosslinking of the core Pol II initiation complex underlines this statement even more
as it shows the conserved architecture. Our proposed model of the conserved
architecture of the ITC was further validated by a later study that combined
crosslinking with single-particle cryo-EM120. Still, many questions regarding the
topology of the core initiation complex remain: Where do the Tfg1 insertion and the
WH domains of TFIIF reside, and does the insertion domain get structured due to
binding to Pol II? Are the Tfg1 arm and the charged helix contacting the DNA strand,
and what function does the negative charge of the charged helix have? Do both
positions of the Tfg2 WH also exist in vivo, and does the Tfg2 WH bind upstream
promoter DNA? Further experiments comprising both structural and biochemical
methods are needed to address these questions. On a structural level, the highest
potential for success will be the combination of X-ray crystallography, single-particle
cryo-EM, mass spectrometric approaches (protein/DNA crosslinking-MS, native-MS,
and hydrogen-deuterium exchange) and computational based methods. Combining
diverse structural restrains deriving from different methods is challenging, but will be
rewarding, as new insights can be gained and misinterpretations can be minimized.
To gain further knowledge on how initiation is regulated, the architecture of
more complete initiation complexes need to be addressed. Therefore, the addition of
GTFs (transcription factor-IIA, -IID, -IIE, IIH) and the Mediator complex to the core
initiation complex are the next logical steps. As crystallization of such big and
potentially flexible complexes can be difficult, single-particle cryo-EM starts to play an
increasingly important role, especially with recent improvements such as the
(introduction of the direct detector121, marking a milestone in generating high
resolution data.
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Based on these high resolution restrains, target sites could be identified for
mutational analysis, addressing central questions, like: What are the functions of the
GTFs modulated; how initiation complexes can form on TATA-less promotors; which
additional, unknown factors bind to the initiation complex or how are coactivators
placed within pre-initiation complexes.
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4.2 The	transcription	elongation	promoting	CTDK-I	complex		
For future work, the arrangement of the CTDK-I complex needs to be further
investigated to reveal the interplay of the three subunits, which is unique among CDK
complexes. The heterodimer Ctk2-Ctk3 represents a promising target for structural
determination by X-ray crystallography, as it was shown to form a stable complex in
gel filtration chromatography67.
A high resolution structure of Ctk2-Ctk3 could provide insights which address
serval central questions: 1) how does the CTDK-I complex approach the Pol II CTD?
2) Which mechanism does allow Ctk3 to act as a co-cyclin and why can’t Ctk2 fulfill
the cyclin functions on its own? 3) Does the non-canonical CID fold of Ctk3 fulfill an
unknown purpose? and 4) Does the highly conserved C-terminal domain of Ctk3
interact with Ctk2 as proposed67.
One general biological question regarding the CTDK-I complex is its role in
connecting gene transcription with cell cycle events. In contrast to most CDKs which
bind different cyclins throughout the cell cycle122, the binding of Ctk1 is specific to
cyclin Ctk2 and the co-cyclin Ctk367. This unique difference compared with other
CDKs could lead to the discovery of a new mechanism in the regulation of CTKs.
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Supplementary	Material	1	
Text and figures of the section Supplementary Material 1 were adapted from Simon
Neyer, who programmed the MATLAB based script which was used as a basis to
generate Figure 2.
BiClAn
BiClAn is a MATLAB® based tool to visualize Bivalent Crosslinking Analysis. It
simplifies cross-link interpretation by converting a list of cross-links to a vector based
diagram. Additionally, it is possible to export a list without redundant distance
restraints.
Supplementary Figure 1: Example of a crosslink map.
In the following, BiClAn is explained by the trimeric complex proteinA/B/C. Intra and
inter cross-links are shown as green and blue lines, respectively, while possible
candidates are colored in red. For proteinA, domains are highlighted. Magenta and
yellow lines represent α-helices and β-strands, respectively.
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Data preparation and input files
As input files, tab delimited *.txt files have to be placed in the folder ‘input’.
The names of these files should reflect what is contained in the variable file within the
main script (BiClAn). The input files are formatted in the way that the third and fourth
column state the position of the cross-links of the subunits given in column one and
two, respectively. The fifth column allows one to mark a cross-link, e.g. as a
candidate and allows to draw it in a different manner (Supplementary Figure 3).
Please note, that inter and intra cross-links have to be provided in separate input
files. The protein names may not include spaces. This is true for all input files.
The variable default loads a tab delimited file which sets the name of the
proteins and allows the subunits to be treated separately (Supplementary Figure 3).
Please note that you have to give the name of the proteins in descending
alphabetical order (as they are called in file). Two additional rows are needed at the
end of the document. The easiest way to generate this file is to use a spreadsheet
program and save as tab delimited *.txt.
The number of amino acids is given in the second column. Although no axes
are displayed, the diagram is an x-y-coordinate system (Supplementary Figure 2).
The value in column eight and nine sets the x- and y-value, respectively. Whether an
operation has (‘1’) or has not (‘0’) to be executed for a specific subunit this can be set
in the residual columns.
Before drawing distance restraints, the user has to choose which input files to
use. As shown in Supplementary Figure 4, this is done by handing over the index of
the input file to variable ‘i’. By executing these functions one by one, cross-links from
different experiments can be drawn in different colors to make them distinguishable.
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Supplementary Figure 2: x-/y- position of protein boxes.
To determine the position of the boxes representing complex subunits, x- and y-
values have to be provided in the default file. They correspond to the middle left edge
of the box. It is recommended to set these values randomly in the first place. For a
second round, optimized positions can be determined by moving the boxes in a
vector based graphics suite.
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Supplementary Figure 3: Input files.
All files required to generate the demo diagram are displayed. As with the others,
default.txt is a tab delimited file. In this figure a screenshot from a spreadsheet
program is shown to highlight the meaning of each column. However, it was saved as
*.txt later on.
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Supplementary Figure 4: Script excerpt.
Parts of the BiClAn script are shown to demonstrate how to choose which dataset
(loaded in file) has to be drawn. The variable ‘i’ sets the index of the respective input
file. In this example intra cross-links of 'demo_intra' are drawn. Inter cross-links from
selected subunits to all subunits are drawn in case of 'demo_inter1' and
'demo_inter1'.
%%%%%%%%%%%%%%%%%%%
%%% input files %%%
%%%%%%%%%%%%%%%%%%%
file = {'demo_inter1' % 1
'demo_inter2' % 2
'demo_intra' % 3
    }
%%%%%%%%%%%%%%%%%%%%%%%%%
%%% intra cross-links %%%
%%%%%%%%%%%%%%%%%%%%%%%%%
i=[3]
param.loop='g'; %color of intra cross links
BiClIntra(param,sorted,file,intra,x,y,i)
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% inter cross links from selected subunits to selected subunits only %%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
i=[]
param.candidate='r'; % color and style of candidates
param.valid='b'; % color of valid cross links
param.width=1;
BiClInter1(param,sorted,file,inter,x,y,i,conc)
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% inter cross links from selected subunits to all subunits %%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
i=[1 2]
param.candidate='r'; % color and style of candidates
param.valid='b'; % color of valid cross links
param.width=1;BiClInter2(param,sorted,file,inter,x,y,i,conc)
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Domains and secondary structure
As optional features, BiClAn offers to display the domain architecture and secondary
structure information of subunits. In this case input files have to follow a specific
nomenclature. Starting with the name as given in default, _sec or _dom is used as
suffix for a tab-delimited *.txt file. H, E and C represent helices, strands and regions
neither forming helices nor strands, respectively. Domain information is given in four
columns. Column one will be neglected by BiClAn, but may not contain spaces. The
second column states the name of the domain, whose boundaries are set in column
three and four.
Output files
The generated MATLAB figure can be saved as a pixel based image (e.g. *.png or
*.jpg) as well as a vector based graphic (e.g. *.eps or *.ai). By changing the size of
the window displaying your diagram you also change the size of the saved image. If
the figures are saved as a graphic, clipping masks might be added. It is possible to
remove those in a vector graphic program.
The variable sorted contains (for each input file individually) a table of unique
cross-links. The name of the involved subunits is represented in column one and two
by the indices as indicated in default (Supplementary Figure 3). The respective amino
acid number is given in column three and four. Whether a cross-link was labeled as a
candidate is displayed in column three.
Support
We are more than happy to help, if you encounter problems while executing this
script. Please, feel free to contact us in this case: simon.neyer@mpibpc.mpg.de
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Supplementary	Material	2	
Supplementary Table 1: Inter protein-protein crosslinks.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Rpb1 938 Foot Rpb10 59 Tail 643,196
Inter Rpb1 368 Active site Rpb11 37 Dimerization 1189,395
Inter Rpb1 461 Active site Rpb11 20 Dimerization 569,828
Inter Rpb1 323 Clamp core Rpb2 471 Fork 454,761
Inter Rpb1 323 Clamp core Rpb2 471 Fork 606,014
Inter Rpb1 323 Clamp core Rpb2 934 Wall 400,63
Inter Rpb1 403 Dock Rpb2 886 Wall 534,472
Inter Rpb1 403 Dock Rpb2 1102 Hybrid binding 728,376
Inter Rpb1 403 Dock Rpb2 1102 Hybrid binding 530,784
Inter Rpb1 695 Funnel Rpb2 972 Wall 616,756
Inter Rpb1 773 Funnel Rpb2 510 Fork 772,906
Inter Rpb1 830 Cleft Rpb2 507 Fork 747,411
Inter Rpb1 830 Cleft Rpb2 510 Fork 747,41
Inter Rpb1 938 Foot Rpb2 813 Hybrid binding 637,547
Inter Rpb1 1102 Cleft Rpb2 507 Fork 513,067
Inter Rpb1 1112 Cleft Rpb2 507 Fork 888,215
Inter Rpb1 15 Clamp core Rpb5 171 Assembly 743,909
Inter Rpb1 129 Clamp head Rpb5 161 Assembly 487,021
Inter Rpb1 129 Clamp head Rpb5 161 Assembly 415,437
Inter Rpb1 129 Clamp head Rpb5 161 Assembly 691,724
Inter Rpb1 129 Clamp head Rpb5 171 Assembly 694,405
Inter Rpb1 129 Clamp head Rpb5 171 Assembly 442,665
Inter Rpb1 129 Clamp head Rpb5 171 Assembly 737,103
Inter Rpb1 129 Clamp head Rpb5 171 Assembly 506,497
Inter Rpb1 132 Clamp head Rpb5 161 Assembly 519,044
Inter Rpb1 132 Clamp head Rpb5 171 Assembly 442,665
Inter Rpb1 132 Clamp head Rpb5 171 Assembly 553,078
Inter Rpb1 934 Foot Rpb5 20 Jaw 538,712
Inter Rpb1 1003 Foot Rpb5 166 Assembly 741,43
Inter Rpb1 1003 Foot Rpb5 197 Assembly 620,114
Inter Rpb1 1003 Foot Rpb5 197 Assembly 826,484
Inter Rpb1 1350 Cleft Rpb5 201 Assembly 824,917
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Continuation of table Supplementary Table 1.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Rpb1 1350 Cleft Rpb5 201 Assembly 1099,553
Inter Rpb1 15 Clamp core Rpb6 72 Assembly 672,626
Inter Rpb1 1003 Foot Rpb6 72 Assembly 698,398
Inter Rpb1 1003 Foot Rpb6 76 Assembly 745,745
Inter Rpb1 977 Foot Rpb8 136 ß-barrel 1126,109
Inter Rpb1 1246 Jaw Rpb9 20 Jaw 731,756
Inter Rpb1 1246 Jaw Rpb9 20 Jaw 557,276
Inter Rpb1 1246 Jaw Rpb9 20 Jaw 835,412
Inter Rpb1 1246 Jaw Rpb9 20 Jaw 832,212
Inter Rpb1 49 Clamp core Tfg1 284 Insertion 1 544,297
Inter Rpb1 1262 Jaw Tfg1 411 Charged region 621,842
Inter Rpb1 1262 Jaw Tfg1 411 Charged region 828,787
Inter Rpb1 49 Clamp core Tfg2 342 WH domain 497,78
Inter Rpb1 49 Clamp core Tfg2 357 C-terminal 703,729
Inter Rpb1 176 Clamp head Tfg2 179 Insertion 562,905
Inter Rpb1 34 Clamp core TFIIB 9 B-ribbon 436,259
Inter Rpb1 34 Clamp core TFIIB 9 B-ribbon 581,345
Inter Rpb1 49 Clamp core TFIIB 9 B-ribbon 482,017
Inter Rpb1 49 Clamp core TFIIB 98 B-linker 572,053
Inter Rpb1 49 Clamp core TFIIB 112 B-linker 517,041
Inter Rpb1 49 Clamp core TFIIB 121 B-linker 478,763
Inter Rpb1 49 Clamp core TFIIB 121 B-linker 638,015
Inter Rpb1 49 Clamp core TFIIB 155 B-core N-term. Cyclin 618,316
Inter Rpb10 59 Tail Rpb2 813 Hybrid binding 731,404
Inter Rpb10 59 Tail Rpb2 813 Hybrid binding 513,956
Inter Rpb10 68 Tail Rpb3 149 Domain2 440,499
Inter Rpb10 68 Tail Rpb3 149 Domain2 469,256
Inter Rpb10 68 Tail Tfg2 290 Linker 663,696
Inter Rpb11 20 Dimerization Rpb1 644 Pore 1 676,374
Inter Rpb11 20 Dimerization Rpb1 644 Pore 1 760,02
Inter Rpb11 26 Dimerization Rpb1 637 Pore 1 811,449
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 763,214
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 1185,636
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 811,448
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 1014,058
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 760,018
Inter Rpb11 26 Dimerization Rpb1 644 Pore 1 949,773
Inter Rpb11 37 Dimerization Rpb3 160 Domain2 659,565
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Continuation of table Supplementary Table 1.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Rpb11 37 Dimerization Rpb3 253 Dimerization 676,175
Inter Rpb12 28 Zinc Ribbon Rpb10 68 Tail 701,595
Inter Rpb12 37 Zinc Ribbon Rpb10 68 Tail 712,102
Inter Rpb12 37 Zinc Ribbon Rpb3 149 Domain2 629,074
Inter Rpb12 37 Zinc Ribbon Rpb3 149 Domain2 838,429
Inter Rpb2 227 Lobe Rpb1 1093 Cleft 543,569
Inter Rpb2 507 Fork Rpb1 1093 Cleft 467,031
Inter Rpb2 507 Fork Rpb1 1093 Cleft 622,371
Inter Rpb2 886 Wall Rpb1 372 Active site 904,472
Inter Rpb2 892 Wall Rpb1 343 Clamp core 623,522
Inter Rpb2 1102 Hybrid binding Rpb1 323 Clamp core 472,462
Inter Rpb2 1102 Hybrid binding Rpb1 343 Clamp core 534,282
Inter Rpb2 1102 Hybrid binding Rpb1 343 Clamp core 481,463
Inter Rpb2 1183 Clamp Rpb1 34 Clamp core 920,13
Inter Rpb2 191 Protrusion Rpb10 68 Tail 748,376
Inter Rpb2 191 Protrusion Rpb10 68 Tail 1035,842
Inter Rpb2 801 Hybrid binding Rpb10 59 Tail 816,439
Inter Rpb2 801 Hybrid binding Rpb10 59 Tail 847,656
Inter Rpb2 864 Wall Rpb12 58 Zinc Ribbon 470,515
Inter Rpb2 191 Protrusion Rpb3 149 Domain2 694,106
Inter Rpb2 191 Protrusion Rpb3 149 Domain2 925,137
Inter Rpb2 1057 Hybrid binding Rpb3 199 Loop 1039,907
Inter Rpb2 1057 Hybrid binding Rpb3 199 Loop 1088,145
Inter Rpb2 87 Protrusion Tfg1 335 Dimerization 507,028
Inter Rpb2 246 Lobe Tfg1 335 Dimerization 634,35
Inter Rpb2 270 Lobe Tfg1 411 Charged region 515,055
Inter Rpb2 277 Lobe Tfg1 411 Charged region 728,181
Inter Rpb2 277 Lobe Tfg1 411 Charged region 970,568
Inter Rpb2 358 Lobe Tfg1 328 Dimerization 739,8
Inter Rpb2 358 Lobe Tfg1 328 Dimerization 924,495
Inter Rpb2 358 Lobe Tfg1 328 Dimerization 638,016
Inter Rpb2 358 Lobe Tfg1 328 Dimerization 765,42
Inter Rpb2 358 Lobe Tfg1 328 Dimerization 680,876
Inter Rpb2 358 Lobe Tfg1 335 Dimerization 691,571
Inter Rpb2 358 Lobe Tfg1 335 Dimerization 864,213
Inter Rpb2 358 Lobe Tfg1 335 Dimerization 597,826
Inter Rpb2 358 Lobe Tfg1 335 Dimerization 717,189
Inter Rpb2 606 External 2 Tfg1 61 N-terminal 687,586
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Continuation of table Supplementary Table 1.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Rpb2 606 External 2 Tfg1 61 N-terminal 726,611
Inter Rpb2 606 External 2 Tfg1 61 N-terminal 638,52
Inter Rpb2 87 Protrusion Tfg2 163 Insertion 465,513
Inter Rpb2 99 Protrusion Tfg2 286 Linker 703,97
Inter Rpb2 133 Protrusion Tfg2 249 Linker 621,088
Inter Rpb2 133 Protrusion Tfg2 249 Linker 660,113
Inter Rpb2 148 Protrusion Tfg2 148 Insertion 874,428
Inter Rpb2 177 Protrusion Tfg2 245 Linker 996,508
Inter Rpb2 191 Protrusion Tfg2 279 Linker 827,659
Inter Rpb2 246 Lobe Tfg2 148 Insertion 675,163
Inter Rpb2 246 Lobe Tfg2 249 Linker 586,656
Inter Rpb2 344 Lobe Tfg2 179 Insertion 623,374
Inter Rpb2 344 Lobe Tfg2 179 Insertion 435,759
Inter Rpb2 344 Lobe Tfg2 179 Insertion 405,647
Inter Rpb2 606 External 2 Tfg2 245 Linker 610,342
Inter Rpb2 606 External 2 Tfg2 245 Linker 813,455
Inter Rpb2 606 External 2 Tfg2 245 Linker 649,367
Inter Rpb2 606 External 2 Tfg2 245 Linker 688,393
Inter Rpb2 606 External 2 Tfg2 279 Linker 683,855
Inter Rpb2 865 Wall Tfg2 279 Linker 797,905
Inter Rpb2 934 Wall Tfg2 286 Linker 415,735
Inter Rpb2 228 Lobe TFIIB 98 B-linker 544,893
Inter Rpb2 228 Lobe TFIIB 98 B-linker 680,865
Inter Rpb2 277 Lobe TFIIB 108 B-linker 754,943
Inter Rpb2 277 Lobe TFIIB 108 B-linker 1006,256
Inter Rpb2 426 Protrusion TFIIB 108 B-linker 510,049
Inter Rpb2 451 Protrusion TFIIB 147 B-core N-ter. cyclin 575,836
Inter Rpb2 458 Protrusion TFIIB 147 B-core N-ter. cyclin 1003,534
Inter Rpb2 458 Protrusion TFIIB 147 B-core N-ter. cyclin 784,924
Inter Rpb2 470 Fork TFIIB 98 B-linker 904,123
Inter Rpb2 892 Wall TFIIB 33 B-ribbon 636,74
Inter Rpb2 892 Wall TFIIB 33 B-ribbon 573,976
Inter Rpb3 154 Domain2 Rpb10 68 Tail 605,324
Inter Rpb3 160 Domain2 Rpb2 934 Wall 607,003
Inter Rpb3 137 Domain2 Tfg2 357 C-terminal 794,182
Inter Rpb4 142 Tip-associated Rpb3 149 Domain2 643,339
Inter Rpb5 171 Assembly Rpb1 129 Clamp head 480,878
Inter Rpb5 201 Assembly Rpb1 938 Foot 415,731
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Continuation of table Supplementary Table 1.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Rpb5 171 Assembly Rpb6 72 Assembly 423,249
Inter Rpb6 72 Assembly Rpb5 166 Assembly 546,342
Inter Rpb7 73 Tip Rpb6 72 Assembly 633,849
Inter Rpb9 93 Zinc Ribbon Rpb1 1093 Cleft 778,197
Inter Rpb9 93 Zinc Ribbon Rpb2 227 Lobe 847,638
Inter Rpb9 77 Zinc Ribbon Tfg1 60 N-terminal 550,78
Inter TBP 97 core-TBP Tfg2 290 Linker 487,267
Inter Tfg1 411 Charged region Rpb1 186 Clamp head 432,502
Inter Tfg1 706 WH domain Rpb1 1217 Jaw 655,37
Inter Tfg1 23 N-terminal Rpb2 655 External 1 736,075
Inter Tfg1 23 N-terminal Rpb2 813 Hybrid binding 653,342
Inter Tfg1 60 N-terminal Rpb2 606 External 2 808,66
Inter Tfg1 61 N-terminal Rpb2 606 External 2 808,659
Inter Tfg1 61 N-terminal Rpb2 606 External 2 678,351
Inter Tfg1 61 N-terminal Rpb2 606 External 2 758,87
Inter Tfg1 61 N-terminal Rpb2 606 External 2 1011,492
Inter Tfg1 61 N-terminal Rpb2 652 External 1 612,321
Inter Tfg1 89 N-terminal Rpb2 606 External 2 758,581
Inter Tfg1 89 N-terminal Rpb2 622 External 2 692,96
Inter Tfg1 328 Dimerization Rpb2 87 Protrusion 567,314
Inter Tfg1 328 Dimerization Rpb2 87 Protrusion 756,081
Inter Tfg1 328 Dimerization Rpb2 246 Lobe 714,73
Inter Tfg1 328 Dimerization Rpb2 246 Lobe 600,586
Inter Tfg1 328 Dimerization Rpb2 426 Protrusion 463,873
Inter Tfg1 328 Dimerization Rpb2 426 Protrusion 579,589
Inter Tfg1 328 Dimerization Rpb2 426 Protrusion 547,565
Inter Tfg1 328 Dimerization Rpb2 426 Protrusion 611,614
Inter Tfg1 61 N-terminal Rpb9 77 Zinc Ribbon 2 777,1
Inter Tfg1 61 N-terminal Tfg2 245 Linker 620,932
Inter Tfg1 61 N-terminal Tfg2 245 Linker 524,071
Inter Tfg1 61 N-terminal Tfg2 245 Linker 654,84
Inter Tfg1 61 N-terminal Tfg2 245 Linker 693,863
Inter Tfg1 61 N-terminal Tfg2 249 Linker 490,242
Inter Tfg1 61 N-terminal Tfg2 279 Linker 728,353
Inter Tfg1 61 N-terminal Tfg2 286 Linker 467,637
Inter Tfg1 61 N-terminal Tfg2 290 Linker 499,055
Inter Tfg1 89 N-terminal Tfg2 94 Dimerization 816,817
Inter Tfg1 89 N-terminal Tfg2 94 Dimerization 952,99
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter Tfg1 91 N-terminal Tfg2 99 Dimerization 798,652
Inter Tfg1 91 N-terminal Tfg2 99 Dimerization 921,787
Inter Tfg1 91 N-terminal Tfg2 127 Dimerization 854,829
Inter Tfg1 108 Dimerization Tfg2 148 Insertion 880,46
Inter Tfg1 184 Insertion 1 Tfg2 148 Insertion 862,208
Inter Tfg1 184 Insertion 1 Tfg2 156 Insertion 869,197
Inter Tfg1 284 Insertion 1 Tfg2 174 Insertion 481,01
Inter Tfg1 335 Dimerization Tfg2 163 Insertion 451,763
Inter Tfg1 335 Dimerization Tfg2 179 Insertion 623,678
Inter Tfg1 616 Insertion 2 Tfg2 156 Insertion 440,907
Inter Tfg2 279 Linker Rpb10 68 Tail 803,413
Inter Tfg2 342 WH domain Rpb10 59 Tail 746,016
Inter Tfg2 348 WH domain Rpb10 59 Tail 746,014
Inter Tfg2 148 Insertion Rpb2 87 Protrusion 574,558
Inter Tfg2 164 Insertion Rpb2 87 Protrusion 575,057
Inter Tfg2 164 Insertion Rpb2 344 Lobe 705,067
Inter Tfg2 164 Insertion Rpb2 344 Lobe 454,664
Inter Tfg2 172 Insertion Rpb2 344 Lobe 568,078
Inter Tfg2 206 Dimerization Rpb2 344 Lobe 537,328
Inter Tfg2 206 Dimerization Rpb2 344 Lobe 768,136
Inter Tfg2 235 Linker Rpb2 606 External 2 982,679
Inter Tfg2 245 Linker Rpb2 246 Lobe 482,53
Inter Tfg2 245 Linker Rpb2 246 Lobe 417,447
Inter Tfg2 342 WH domain Rpb2 813 Hybrid binding 611,928
Inter Tfg2 348 WH domain Rpb2 813 Hybrid binding 732,634
Inter Tfg2 348 WH domain Rpb2 813 Hybrid binding 764,658
Inter Tfg2 348 WH domain Rpb2 813 Hybrid binding 1019,207
Inter Tfg2 359 C-terminal Rpb3 149 Domain2 443,503
Inter Tfg2 127 Dimerization Tfg1 126 Dimerization 607,668
Inter Tfg2 127 Dimerization Tfg1 126 Dimerization 729,001
Inter Tfg2 127 Dimerization Tfg1 389 Dimerization 716,133
Inter Tfg2 148 Insertion Tfg1 335 Dimerization 747,405
Inter Tfg2 156 Insertion Tfg1 335 Dimerization 756,728
Inter Tfg2 156 Insertion Tfg1 616 Insertion 2 528,887
Inter Tfg2 164 Insertion Tfg1 284 Insertion 1 581,306
Inter Tfg2 164 Insertion Tfg1 335 Dimerization 748,07
Inter Tfg2 206 Dimerization Tfg1 335 Dimerization 569,578
Inter Tfg2 235 Linker Tfg1 61 N-terminal 961,247
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Inter TFIIB 98 B-linker Rpb2 246 Lobe 523,773
Inter TFIIB 98 B-linker Rpb2 426 Protrusion 567,062
Inter TFIIB 98 B-linker Rpb2 471 Fork 641,992
Inter TFIIB 98 B-linker Rpb2 864 Wall 758,364
Inter TFIIB 108 B-linker Rpb2 426 Protrusion 478,025
Inter TFIIB 151 B-core N-ter. cyclinRpb2 864 Wall 717,331
Inter TFIIB 9 B-ribbon Rpb7 27 Tip 650,364
Inter TFIIB 155 B-core N-ter. cyclinTfg2 286 Linker 641,817
Inter TFIIB 161 B-core N-ter. cyclinTfg2 179 Insertion 451,247
Inter TFIIB 199 B-core N-ter. cyclinTfg2 279 Linker 890,491
Inter TFIIB 199 B-core N-ter. cyclinTfg2 286 Linker 524,064
Inter TFIIB 199 B-core N-ter. cyclinTfg2 286 Linker 698,417
Inter TFIIB 199 B-core N-ter. cyclinTfg2 290 Linker 563,335
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Supplementary Table 2: Intra protein-protein crosslinks.
Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Rpb1 101 Clamp head Rpb1 143 Clamp head 640,71
Intra Rpb1 143 Clamp head Rpb1 186 Clamp head 574,075
Intra Rpb1 143 Clamp head Rpb1 186 Clamp head 613,1
Intra Rpb1 368 Active site Rpb1 461 Active site 907,509
Intra Rpb1 372 Active site Rpb1 403 Dock 1290,352
Intra Rpb1 372 Active site Rpb1 403 Dock 968,011
Intra Rpb1 403 Dock Rpb1 343 Clamp core 616,828
Intra Rpb1 431 Dock Rpb1 343 Clamp core 644,593
Intra Rpb1 644 Pore 1 Rpb1 461 Active site 969,538
Intra Rpb1 644 Pore 1 Rpb1 461 Active site 727,408
Intra Rpb1 695 Funnel Rpb1 789 Funnel 721,18
Intra Rpb1 705 Funnel Rpb1 689 Funnel 706,155
Intra Rpb1 705 Funnel Rpb1 689 Funnel 898,507
Intra Rpb1 705 Funnel Rpb1 1093 Cleft 912,173
Intra Rpb1 705 Funnel Rpb1 1093 Cleft 547,707
Intra Rpb1 705 Funnel Rpb1 1286 Cleft 978,177
Intra Rpb1 705 Funnel Rpb1 1286 Cleft 587,31
Intra Rpb1 705 Funnel Rpb1 1286 Cleft 765,911
Intra Rpb1 773 Funnel Rpb1 1093 Cleft 837,685
Intra Rpb1 830 Cleft Rpb1 1093 Cleft 737,155
Intra Rpb1 830 Cleft Rpb1 1102 Cleft 1043,918
Intra Rpb1 880 Foot Rpb1 620 Pore 1 967,99
Intra Rpb1 991 Foot Rpb1 938 Foot 740,942
Intra Rpb1 1102 Cleft Rpb1 1093 Cleft 502,809
Intra Rpb1 1112 Cleft Rpb1 773 Funnel 1007,295
Intra Rpb1 1112 Cleft Rpb1 1093 Cleft 877,958
Intra Rpb1 1112 Cleft Rpb1 1102 Cleft 1231,659
Intra Rpb1 1132 Cleft Rpb1 705 Funnel 1107,838
Intra Rpb1 1132 Cleft Rpb1 1205 Jaw 1103,306
Intra Rpb1 1132 Cleft Rpb1 1286 Cleft 743,99
Intra Rpb1 1246 Jaw Rpb1 1217 Jaw 800,421
Intra Rpb1 1246 Jaw Rpb1 1221 Jaw 933,255
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Rpb11 37 Dimerization Rpb11 20 Dimerization 681,576
Intra Rpb11 55 Dimerization Rpb11 88 Dimerization 704,985
Intra Rpb11 88 Dimerization Rpb11 55 Dimerization 846,465
Intra Rpb12 28 Zinc Ribbon Rpb12 49 Zinc Ribbon 901,08
Intra Rpb2 99 Protrusion Rpb2 164 Protrusion 1046,512
Intra Rpb2 148 Protrusion Rpb2 87 Protrusion 1096,034
Intra Rpb2 228 Lobe Rpb2 257 Lobe 1013,244
Intra Rpb2 228 Lobe Rpb2 270 Lobe 552,926
Intra Rpb2 228 Lobe Rpb2 507 Fork 625,113
Intra Rpb2 246 Lobe Rpb2 426 Protrusion 626,354
Intra Rpb2 246 Lobe Rpb2 426 Protrusion 470,018
Intra Rpb2 277 Lobe Rpb2 228 Lobe 904,027
Intra Rpb2 277 Lobe Rpb2 471 Fork 704,908
Intra Rpb2 358 Lobe Rpb2 246 Lobe 846,949
Intra Rpb2 358 Lobe Rpb2 246 Lobe 677,761
Intra Rpb2 358 Lobe Rpb2 246 Lobe 703,384
Intra Rpb2 358 Lobe Rpb2 344 Lobe 831,961
Intra Rpb2 426 Protrusion Rpb2 246 Lobe 401,835
Intra Rpb2 426 Protrusion Rpb2 246 Lobe 502,042
Intra Rpb2 426 Protrusion Rpb2 471 Fork 460,015
Intra Rpb2 426 Protrusion Rpb2 471 Fork 427,99
Intra Rpb2 451 Protrusion Rpb2 470 Fork 978,21
Intra Rpb2 458 Protrusion Rpb2 471 Fork 714,375
Intra Rpb2 458 Protrusion Rpb2 864 Wall 801,654
Intra Rpb2 458 Protrusion Rpb2 864 Wall 833,678
Intra Rpb2 470 Fork Rpb2 246 Lobe 613,324
Intra Rpb2 470 Fork Rpb2 423 Protrusion 656,612
Intra Rpb2 470 Fork Rpb2 426 Protrusion 875,146
Intra Rpb2 470 Fork Rpb2 426 Protrusion 656,612
Intra Rpb2 507 Fork Rpb2 471 Fork 425,993
Intra Rpb2 864 Wall Rpb2 934 Wall 507,752
Intra Rpb2 864 Wall Rpb2 934 Wall 676,666
Intra Rpb2 865 Wall Rpb2 451 Protrusion 657,162
Intra Rpb2 865 Wall Rpb2 934 Wall 704,361
Intra Rpb2 876 Wall Rpb2 451 Protrusion 657,162
Intra Rpb2 876 Wall Rpb2 451 Protrusion 821,2
Intra Rpb2 886 Wall Rpb2 864 Wall 842,415
Intra Rpb2 886 Wall Rpb2 934 Wall 495,501
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Rpb2 892 Wall Rpb2 864 Wall 674,134
Intra Rpb2 892 Wall Rpb2 934 Wall 736,127
Intra Rpb2 892 Wall Rpb2 934 Wall 589,102
Intra Rpb2 892 Wall Rpb2 934 Wall 640,93
Intra Rpb2 979 Hybrid binding Rpb2 1102 Hybrid binding 518,878
Intra Rpb2 987 Hybrid binding Rpb2 979 Hybrid binding 675,62
Intra Rpb2 987 Hybrid binding Rpb2 1102 Hybrid binding 538,687
Intra Rpb2 987 Hybrid binding Rpb2 1102 Hybrid binding 673,106
Intra Rpb2 987 Hybrid binding Rpb2 1102 Hybrid binding 592,524
Intra Rpb2 987 Hybrid binding Rpb2 1102 Hybrid binding 475,089
Intra Rpb2 1102 Hybrid binding Rpb2 471 Fork 408,412
Intra Rpb2 1102 Hybrid binding Rpb2 864 Wall 597,544
Intra Rpb2 1102 Hybrid binding Rpb2 886 Wall 468,436
Intra Rpb2 1102 Hybrid binding Rpb2 934 Wall 445,032
Intra Rpb2 1102 Hybrid binding Rpb2 972 Wall 615,584
Intra Rpb2 1102 Hybrid binding Rpb2 972 Wall 546,505
Intra Rpb2 1102 Hybrid binding Rpb2 979 Hybrid binding 572,715
Intra Rpb2 1174 Clamp Rpb2 1188 Clamp 850,595
Intra Rpb3 15 Dimerization Rpb3 137 Domain2 1191,863
Intra Rpb3 165 Domain2 Rpb3 160 Domain2 453,262
Intra Rpb3 165 Domain2 Rpb3 253 Dimerization 674,397
Intra Rpb4 121 Tip-associated Rpb4 60 Tip-associated 881,734
Intra Rpb4 142 Tip-associated Rpb4 60 Tip-associated 760,166
Intra Rpb5 45 Jaw Rpb5 20 Jaw 610,81
Intra Rpb5 45 Jaw Rpb5 20 Jaw 514,468
Intra Rpb5 45 Jaw Rpb5 20 Jaw 642,832
Intra Rpb5 171 Assembly Rpb5 161 Assembly 486,271
Intra Rpb5 171 Assembly Rpb5 166 Assembly 417,849
Intra Rpb5 197 Assembly Rpb5 201 Assembly 493,539
Intra Rpb6 76 Assembly Rpb6 128 Assembly 561,321
Intra TBP 83 core-TBP TBP 97 core-TBP 473,866
Intra TBP 151 core-TBP TBP 133 core-TBP 830,423
Intra TBP 151 core-TBP TBP 133 core-TBP 623,069
Intra TBP 151 core-TBP TBP 133 core-TBP 655,093
Intra TBP 156 core-TBP TBP 133 core-TBP 1039,181
Intra TBP 156 core-TBP TBP 133 core-TBP 779,638
Intra Tfg1 61 N-terminal Tfg1 89 N-terminal 587,799
Intra Tfg1 89 N-terminal Tfg1 61 N-terminal 794,181
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Tfg1 91 N-terminal Tfg1 61 N-terminal 885,413
Intra Tfg1 120 Dimerization Tfg1 389 Dimerization 531,556
Intra Tfg1 126 Dimerization Tfg1 120 Dimerization 555,72
Intra Tfg1 184 Insertion 1 Tfg1 267 Insertion 1 1014,788
Intra Tfg1 267 Insertion 1 Tfg1 284 Insertion 1 733,392
Intra Tfg1 288 Insertion 1 Tfg1 279 Insertion 1 1265,589
Intra Tfg1 406 Charged region Tfg1 411 Charged region 773,744
Intra Tfg1 421 Charged region Tfg1 406 Charged region 1111,911
Intra Tfg1 421 Charged region Tfg1 406 Charged region 834,183
Intra Tfg1 591 Insertion 2 Tfg1 522 Insertion 2 519,774
Intra Tfg1 591 Insertion 2 Tfg1 529 Insertion 2 488,602
Intra Tfg1 591 Insertion 2 Tfg1 579 Insertion 2 522,613
Intra Tfg1 599 Insertion 2 Tfg1 719 WH domain 599,718
Intra Tfg1 690 WH domain Tfg1 706 WH domain 491,768
Intra Tfg1 690 WH domain Tfg1 706 WH domain 655,356
Intra Tfg1 706 WH domain Tfg1 690 WH domain 424,836
Intra Tfg1 706 WH domain Tfg1 690 WH domain 530,794
Intra Tfg1 706 WH domain Tfg1 714 WH domain 430,65
Intra Tfg1 714 WH domain Tfg1 706 WH domain 499,035
Intra Tfg1 719 WH domain Tfg1 529 Insertion 2 537,286
Intra Tfg1 719 WH domain Tfg1 690 WH domain 460,845
Intra Tfg1 719 WH domain Tfg1 690 WH domain 486,464
Intra Tfg1 719 WH domain Tfg1 706 WH domain 611,318
Intra Tfg1 719 WH domain Tfg1 706 WH domain 489,254
Intra Tfg1 719 WH domain Tfg1 706 WH domain 458,034
Intra Tfg1 719 WH domain Tfg1 706 WH domain 429,23
Intra Tfg1 719 WH domain Tfg1 706 WH domain 604,317
Intra Tfg1 719 WH domain Tfg1 714 WH domain 492,278
Intra Tfg1 719 WH domain Tfg1 714 WH domain 517,898
Intra Tfg1 719 WH domain Tfg1 714 WH domain 819,793
Intra Tfg1 719 WH domain Tfg1 714 WH domain 615,097
Intra Tfg1 728 C-terminal Tfg1 690 WH domain 486,465
Intra Tfg1 728 C-terminal Tfg1 714 WH domain 492,278
Intra Tfg2 80 N-terminal Tfg2 245 Linker 593,339
Intra Tfg2 127 Dimerization Tfg2 99 Dimerization 717,386
Intra Tfg2 141 Dimerization Tfg2 148 Insertion 823,691
Intra Tfg2 141 Dimerization Tfg2 148 Insertion 1055,219
Intra Tfg2 142 Dimerization Tfg2 179 Insertion 451,505
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Tfg2 147 Insertion Tfg2 164 Insertion 503,27
Intra Tfg2 147 Insertion Tfg2 179 Insertion 535,541
Intra Tfg2 148 Insertion Tfg2 142 Dimerization 410,024
Intra Tfg2 148 Insertion Tfg2 163 Insertion 692,055
Intra Tfg2 148 Insertion Tfg2 164 Insertion 795,412
Intra Tfg2 148 Insertion Tfg2 164 Insertion 838,112
Intra Tfg2 148 Insertion Tfg2 164 Insertion 503,268
Intra Tfg2 148 Insertion Tfg2 174 Insertion 704,384
Intra Tfg2 148 Insertion Tfg2 174 Insertion 528,539
Intra Tfg2 148 Insertion Tfg2 174 Insertion 454,252
Intra Tfg2 148 Insertion Tfg2 179 Insertion 713,721
Intra Tfg2 148 Insertion Tfg2 179 Insertion 713,719
Intra Tfg2 148 Insertion Tfg2 179 Insertion 535,541
Intra Tfg2 148 Insertion Tfg2 186 Insertion 507,025
Intra Tfg2 156 Insertion Tfg2 163 Insertion 701,377
Intra Tfg2 156 Insertion Tfg2 164 Insertion 847,434
Intra Tfg2 156 Insertion Tfg2 174 Insertion 574,557
Intra Tfg2 163 Insertion Tfg2 174 Insertion 653,71
Intra Tfg2 164 Insertion Tfg2 142 Dimerization 544,8
Intra Tfg2 164 Insertion Tfg2 174 Insertion 747,745
Intra Tfg2 164 Insertion Tfg2 179 Insertion 714,383
Intra Tfg2 164 Insertion Tfg2 179 Insertion 429,032
Intra Tfg2 172 Insertion Tfg2 142 Dimerization 544,799
Intra Tfg2 172 Insertion Tfg2 173 Insertion 561,061
Intra Tfg2 172 Insertion Tfg2 179 Insertion 568,063
Intra Tfg2 172 Insertion Tfg2 185 Insertion 431,839
Intra Tfg2 172 Insertion Tfg2 186 Insertion 539,546
Intra Tfg2 174 Insertion Tfg2 163 Insertion 558,991
Intra Tfg2 179 Insertion Tfg2 163 Insertion 611,024
Intra Tfg2 185 Insertion Tfg2 179 Insertion 446,253
Intra Tfg2 206 Dimerization Tfg2 174 Insertion 758,78
Intra Tfg2 279 Linker Tfg2 245 Linker 579,823
Intra Tfg2 279 Linker Tfg2 249 Linker 537,536
Intra Tfg2 279 Linker Tfg2 286 Linker 509,281
Intra Tfg2 279 Linker Tfg2 290 Linker 548,552
Intra Tfg2 286 Linker Tfg2 249 Linker 524,303
Intra Tfg2 290 Linker Tfg2 284 Linker 581,348
Intra Tfg2 297 WH domain Tfg2 290 Linker 531,558
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Linked Domain Linked Domain
Link Type Protein 1 residue 1 protein 1 Protein 2 residue 2 protein 2 M/z
Intra Tfg2 330 WH domain Tfg2 341 WH domain 874,157
Intra Tfg2 330 WH domain Tfg2 341 WH domain 655,869
Intra Tfg2 335 WH domain Tfg2 279 Linker 663,105
Intra Tfg2 335 WH domain Tfg2 290 Linker 558,319
Intra Tfg2 335 WH domain Tfg2 297 WH domain 646,112
Intra Tfg2 335 WH domain Tfg2 357 C-terminal 782,098
Intra Tfg2 335 WH domain Tfg2 359 C-terminal 739,4
Intra Tfg2 348 WH domain Tfg2 316 WH domain 944,493
Intra Tfg2 348 WH domain Tfg2 316 WH domain 755,793
Intra Tfg2 348 WH domain Tfg2 341 WH domain 657,876
Intra Tfg2 356 C-terminal Tfg2 179 Insertion 637,622
Intra Tfg2 356 C-terminal Tfg2 342 WH domain 537,049
Intra Tfg2 356 C-terminal Tfg2 359 C-terminal 535,293
Intra Tfg2 356 C-terminal Tfg2 359 C-terminal 567,317
Intra TFIIB 33 B-ribbon TFIIB 9 B-ribbon 497,033
Intra TFIIB 98 B-linker TFIIB 108 B-linker 531,781
Intra TFIIB 98 B-linker TFIIB 112 B-linker 711,37
Intra TFIIB 98 B-linker TFIIB 112 B-linker 533,782
Intra TFIIB 98 B-linker TFIIB 161 B-core N-ter. cyclin 597,805
Intra TFIIB 108 B-linker TFIIB 121 B-linker 584,319
Intra TFIIB 112 B-linker TFIIB 121 B-linker 586,986
Intra TFIIB 116 B-linker TFIIB 98 B-linker 591,556
Intra TFIIB 116 B-linker TFIIB 108 B-linker 502,52
Intra TFIIB 116 B-linker TFIIB 108 B-linker 534,544
Intra TFIIB 116 B-linker TFIIB 108 B-linker 427,837
Intra TFIIB 116 B-linker TFIIB 161 B-core N-ter. cyclin 600,567
Intra TFIIB 132 B-core N-ter. cyclinTFIIB 98 B-linker 920,706
Intra TFIIB 155 B-core N-ter. cyclinTFIIB 9 B-ribbon 726,357
Intra TFIIB 155 B-core N-ter. cyclinTFIIB 98 B-linker 635,056
Intra TFIIB 155 B-core N-ter. cyclinTFIIB 121 B-linker 722,019
Intra TFIIB 155 B-core N-ter. cyclinTFIIB 217 B-core N-ter. cyclin 804,059
Intra TFIIB 155 B-core N-ter. cyclinTFIIB 217 B-core N-ter. cyclin 603,296
Intra TFIIB 161 B-core N-ter. cyclinTFIIB 9 B-ribbon 676,684
Intra TFIIB 161 B-core N-ter. cyclinTFIIB 112 B-linker 542,791
Intra TFIIB 161 B-core N-ter. cyclinTFIIB 121 B-linker 672,35
Intra TFIIB 211 B-core N-ter. cyclinTFIIB 217 B-core N-ter. cyclin 778,436
Intra TFIIB 217 B-core N-ter. cyclinTFIIB 161 B-core N-ter. cyclin 453,035
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Supplementary Table 3: Protein crosslinks, originating from the cross-reactivity.
(formation of N-hydroxyl succinimide ester).
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List of abbreviations
Å Angstrom
ATP Adenosine triphosphate
Amp Ampicillin
BRE TFIIB recognition element
BLAST Basic Local Alignment Search Tool
Ca Candida albicans
C-terminus Carboxy-terminus
CDK Cyclin-dependent kinase
CID C-terminal domain
cITC core Initially Transcribing Complex
CPE core promoter elements
CV Column volume
CTD Carboxy-terminal domain
CTDK-I CTD kinase I
CTK1 CTD kinase subunit alpha
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
DPE Downstream promoter element
DSS Di-succinimidyl-suberate
DTT 1,4-dithio-D,L-threitol
E. coli Escherichia coli
EF E longation factors
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EM Electron microscopy
EDTA Ethylenediaminetetraacetic acid
EPE ligand b4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
GTF General transcription factor
His-tag Histidine-tag
HMMs Hidden Markov models
Hs Homo sapiens
IPTG Isopropyl-b-d-thiogalactoside
Inr Initiator sequence
I-TASSER Iterative Threading ASSEmbly Refinement
Kan Kanamycin
Kp Komagataella pastoris
MAD Multi-wavelength anomalous diffraction
mRNA messenger ribonuecleic acid
N-terminus Amino-terminus
NEB New England Biolabs
OD600 Optical density at 600 nm
ORF Open reading frame
pA Polyadenylation
PAGE Polyacrylamide gel electrophoresis
Pb Paracoccidioides brasiliensis
PCR Polymerase Chain Reaction
PDB Protein data bank
PEG Polyethylene glycol
PIC Pre-initiation complex
Pol II RNA Polymerase II
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pTEF-b positive transcription elongation factor
RMSD Root-mean-square deviation
RNA Ribonuecleic acid
Sc Saccharomyces cerevisiae
SDS Sodium dedocyl sulfate
SeMet selenomethionine
Sm Saccharomyces mikatae
Sp Schizosaccharomyces pombe
TBP Tata-box binding protein
TCEP Tris(2-carboxyethyl)phosphin
TEC Transcription elongation complex
TFII Transcription factor II
WH winged helix
XL-MS Crosslinking coupled to mass spectrometry
List of figures
100
List of figures
Figure 1: Promoter recognition and assembly of the PIC… ...................... 14
Figure 2: Preparation and XL-MS analysis of the yeast core ITC. ............ 38
Figure 3: Crosslinking-derived model of the yeast core ITC. .................... 43
Figure 4: CTDK-I domains and conservation of Ctk3 N-terminal domain. . 48
Figure 5: Crystal structure of the Ctk3 N-terminal domain.. ...................... 50
Figure 6: Surface properties of the Ctk3 N-terminal domain structure.. .... 52
Figure 7: Ctk3 N-terminal domain does not bind CTD phosphopeptides.. 54
Figure 8: The Ctk3 C-terminal region ....................................................... 56
Figure 9: Overview of CTDK-I architecture. .............................................. 58
Supplementary Figure 1: Example of a crosslink map.. ....................... 77
Supplementary Figure 2: x-/y- position of protein boxes.. ...................  79
Supplementary Figure 3: Input files.  .................................................... 80
Supplementary Figure 4: Script excerpt. .............................................  81
List of tables
101
List of tables
Table 1: Pol II, its corresponding General Transcription Factors and the
coactivators. ............................................................................................. 15
Table 2: Bacterial- and Yeast strains. ..................................................... 21
Table 3: Plasmids used in this study. ..................................................... 22
Table 4: Oligonucleotides used for Protein crosslinking. ....................... 22
Table 5: Growth media for E. coli and S. cerevisiae cultures................. 23
Table 6: Additives for E. coli cultures. .................................................... 23
Table 7: List of general buffers and solutions. ........................................ 24
Table 8: Observed lysine-lysine crosslinks in the yeast core Pol II ITC. 41
Table 9: Crystallographic diffraction data and refinement statistic. ........ 47
Supplementary Table 1: Inter protein-protein crosslinks. ..................... 83
Supplementary Table 2: Intra protein-protein crosslinks. ..................... 90
Supplementary Table 3: Protein crosslinks, originating from the cross-
reactivity. .................................................................................................. 96
